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1ABSTRACT
The mammalian neurotrophins: Nerve growth factor (NGF), Brain-derived
neurotrophic factor (BDNF), Neurotrophin-3 (NT-3) and Neurotrophin-4/5 (NT-4/5),
comprise a group of proteins that are essential for differentiation, growth and survival
of various populations of neurons as well as some non-neuronal cells. They signal via
ligand specific Trk receptor tyrosine kinases A, B and C, as well as the common
neurotrophin receptor p75NTR, which belongs to the family of tumor necrosis factor
receptors.
The effects of BDNF on neurotransmission in developing and mature neurons have
been partly associated with the regulation of GABAergic transmission, the main
inhibitory system in the brain, and in particular with GABA
A
-mediated responses. The
polarity of these GABAergic responses is dependent on the concentration of
intracellular chloride, which is controlled by the activity of the K+/Cl- cotransporter
KCC2, a member of the cation chloride cotransporter family (CCC).
The expression of neurotrophins is affected by both physiological (e.g.
developmental changes, functional state) and pathophysiological (e.g. epileptogenesis,
trauma, etc.) conditions. KCC2 expression is also modulated under these conditions.
The time course of theses changes, e.g. along the transition from an immature to a
mature neuronal phenotype, or after axotomy of adult neurons, often coincides with
the respective changes in the regulation of neurotrophins. Therefore, in this study, we
investigated whether neurotrophins regulate KCC2 during development and under
pathological situations.
We observed that KCC2 and BDNF expressions are regulated in a mirror fashion
in hippocampal neurons after kindling, a widely studied in vivo model of
epileptogenesis and neuronal plasticity (I). This pointed us to investigate whether
BDNF directly regulates KCC2 expression. Under Mg2+-free conditions, an in vitro
model of sustained interictal-like activity induced by the absence of Mg2+, we
demonstrated that BDNF and NT-4/5 cause a TrkB-mediated down-regulation of
KCC2 mRNA and protein in adult hippocampal neurons in acute organotypic slice
cultures. Consistently, this treatment also resulted in a reduced capacity for neuronal
Cl- extrusion (I, III). Furthermore, after developing a new technical approach to study
surface membrane trafficking on hippocampal slices, we demonstrated that altered
activity affects the stability of KCC2 under 0-Mg2+ conditions increasing the turnover
of plasmalemmal KCC2 (II, III). Studies using transgenic mice demonstrated that the
molecular mechanism behind the activity-dependent regulation of KCC2, involves
BDNF/TrkB down-stream cascades of both Shc/FRS-2 and PLCγ-CREB signalling
(III).
Finally, we studied the effect of neurotrophins on KCC2 under pathological
conditions. To this end, we used an in vivo axotomy model of adult corticospinal
neurons (CSNs) combined with intracortical neurotrophin application. Here, we
demonstrated that after axotomy, adult CSN undergo a temporary switch to a
developmental mode in their BDNF-mediated KCC2 regulation as well as in their
Abstract
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2trophic dependencies. This ontogenetic reactivation implies an up-regulation of KCC2
under the effect of BDNF and a BDNF dependency, which appears to be restricted to
survival regulation (IV).
Overall, the results presented in this thesis reveal a novel mechanism whereby
BDNF/TrkB signaling suppresses chloride-dependent fast GABA
A
-mediated responses
by modulating KCC2. This is most likely contributing to the well-known role of TrkB-
activated signaling cascades in the induction and establishment of epileptic activity,
and provides a novel role for changes in KCC2 expression in diverse manifestations
of neuronal plasticity. Additionally, the results demonstrate that injury in the adult brain
induces a switch in neurotrophin-mediated survival and KCC2-regulation back to a
mode normally seen in immature neurons, which are probably interacting to regulate
neuronal survival and to promote recovery in a critical post-injury phase.
Abstract
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31. REVIEW OF THE LITERATURE
1.1 NEUROTROPHINS
1.1.1 Neurotrophins: Family ligands
and receptors
The neurotrophin family of growth
factors (NTs), belong to the functionally
related neurotrophic factor family (see
Table 1). This is a broad family of
proteins that after being secreted bind to
cell surface receptors initiating
intracellular signaling cascades that result
in an extensive variety of biological
effects.
The neurotrophins were initially
described as target-derived trophic factors
required for the survival of specific
neuronal populations. Secreted at limiting
amounts, these factors are thought to
ensure a balance between the size of a
target organ and the number of
innervating neurons. According to this
concept, during the development, those
neurons that are sufficiently supplied
Table 1. Families of neurotrophic factors*
Review of the Literature
p
Neurotrophins
 Nerve Growth Factor (NGF)
 Brain-derived Neurotrophic factor (BDNF)
 Neurotrophin-3 (NT-3)
 Neurotrophin-4/5 (NT-4/5)
 Neurotrophin-6 (NT-6)
 Neurotrophin-7 (NT-7)
Neuropoietins
 Ciliary Neurotrophic Factor (CNTF)
 Interleukin-6 (IL-6)
 Leukemia Inhibitory Factor (LIF)
Transforming Growth Factors
 Transforming Growth Factor α (TGFα)
 Transforming Growth Factor β(TGFβ1, TGFβ2, TGFβ3, Bone Morphogenetic 
proteins (BMPs))
o Glial Cell Line -Derived Neurotrophic Factor (GDNF)
o Neurturin (NRTN)
o Persephin (PSPN)
o Artemin (ARTN)
Fibroblast Growth Factors
 Acidic Fibroblast Growth Factor (FGF-1)
 Basic Fibroblast Growth Factor (FGF-2)
 Fibroblast Growth Factor-5 (FGF-5)
Other factors
 Platelet-Derived Growth Factor (PDGF)
 Stem Cell Factor (SCF)
 Vascular Endothelial Growth Factor (VEGF)
 Insulin-like Growth Factors 1-2 (IGF1, IGF-2)
 Epidermal Growth Factors (EGF)
* Adapted from Huang and Reichardt, 2001; Airaksinen and Saarma, 2002; de Caestecker, 
2004; Wong and Guillaud, 2004.
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4with NTs survive, while the others die
(reviewed in Huang and Reichardt, 2001).
Since this initial definition, a great
advance in the study of these molecules
has been made revealing a family of
growth factors of outstanding importance
in the regulation of many functions for
developing and mature cells of the central
and peripheral nervous system. To name
a few functions, NTs regulate neuronal
and glial survival, axonal and dendritic
growth and guidance, synaptic structure
and function, neurotransmitter release,
and synaptic plasticity (reviewed in
McAllister et al., 1999; Huang and
Reichardt, 2001; Poo, 2001). During
early stages of development,
neurotrophins predominantly regulate
cell fate decisions and neuronal survival,
whereas during maturation, their
regulatory repertoire shifts towards
functions in neuronal plasticity, synaptic
transmission, or the maintenance of a
differentiated neuronal phenotype
(Huang and Reichardt, 2001).
1.1.1.1 Ligands
The first neurotrophin reported, Nerve
growth factor (NGF), was identified more
than 50 years ago by Rita Levi-
Montalcini, Viktor Hamburger and
Stanley Cohen, when searching for
target-derived factors that support the
survival and growth of motor and sensory
neurons (reviewed in Levi-Montalcini,
1987). Since then, more molecules have
been incorporated to the family: Brain-
derived neurotrophic factor (BDNF),
being the first molecule of this kind
found in the CNS (Barde et al., 1982;
Leibrock et al., 1989), Neurotrophin-3
(NT-3; Ernfors et al., 1990; Maisonpierre
et al., 1990); Neurotrophin-4/5 (NT-4/5;
Berkemeier et al., 1991; Hallböök et al.,
1991), and neurotrophin-6 (NT-6) and
neurotrophin-7 (NT-7); (Gotz et al., 1994;
Lai et al., 1998). So far, the two latter
have been found only in fish.
The four mammalian neurotrophins
are stable, basic dimeric proteins of about
12kDa, and are expressed at very low
levels during development. They share
about 50% amino acid sequence identity
and their three dimensional structure is
similar to NGF (McDonald et al., 1991;
Ibañez, 1998). The NTs are all
synthesized as prepro-proteins. The
proNTs that result after the signal peptide
is cleaved off, accumulate in prevesicles
en route to be secreted in the constitutive
(spontaneous, independent of
intracellular Ca2+) or regulated (response
to external stimuli, Ca2+- dependent and
lipid environment specific) secretory
pathway (reviewed in Lessmann et al.,
2003). Cleavage of the pro-domain by
proteases results in mature forms of NT.
Once the NTs are released, their
biologically active homodimeric forms
bind to their receptors (see below). These
ligand-receptor complexes are
subsequently incorporated as signaling
endosomes at pre- and/or postsynaptic
compartments (i.e. according to autocrine
or paracrine NT action), which are then
retrogradely or anterogradely transported
to perikaryal sites (Fig. 1; for review see
Lessmann et al., 2003). The process of
maturation seems to play a major role in
the control of neurotrophin activity as
revealed recently by Lee and
collaborators (Lee et al., 2001) when
studying NGF, BDNF, and their non-
processed pro-forms. These studies
suggest that the pro-form and mature
forms bind different neurotrophin
receptors, with the pro-form displaying
Review of the Literature
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5high affinity binding to the common
neurotrophin receptor p75NTR (see below),
and the mature form preferentially
activating Trk receptors. Theses findings
could be physiologically significant
because the neurotrophin precursors are
the predominant forms of BDNF and
NGF in the brain, and have been shown to
accumulate in neurodegenerative diseases
such as Alzheimer’s disease (Fahnestock
et al., 2001; Lee et al., 2001; reviewed in
Chao, 2003). Indeed, proNeurotrophins
are secreted as p75NTR ligand in vivo
where they induce p75NTR -mediated
death in damaged neurons (Harrington et
al., 2004). Whether proNeurotrophins
play a role during development is
unknown.
The expression of NTs in the
mammalian brain is regulated during
development and by neuronal activity.
NT-3 shows the highest expression levels
of all NTs during the perinatal period
(Zhou and Rush, 1994) with most
prominent expression in the
hippocampus, neocortex and cerebellum.
Fig. 1. Neurotrophin synthesis, transport and secretion. A) Neurotrophins are synthesized as
prepro-proteins. Their mature forms (depicted as NT) result from cleavage by specific pro-
teases before they are packed into vesicles in order to be secreted. In addition, unprocessed
forms (proNT) are also secreted. B) Regulated secretion is linked to an increase in [Ca2+]i.
After release NT bind Trk and p75NRT, whereas proNT only bind p75NRT. C) The complex
formed by the NTs and proNTs and their receptors are internalized in the pre- or postsynaptic
membrane (depending on their location and autocrine or paracrine actions) and the signaling
endosomes are transported anterogradely or retrogradely resulting in biological effects. Syn-
aptic activity may regulate the synthesis, packaging and transport of NTs and their receptors
(showed by a lightning arrow).
Review of the Literature
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6BDNF expression levels are low at birth
but increase dramatically during the first
weeks of postnatal development
becoming abundant in hippocampus,
neocortex, amygdala and cerebellum. In
the adult, expression levels of NT-3 and
BDNF are comparable in most areas of
the brain (Hofer et al., 1990;
Maisonpierre et al., 1990; Ernfors et al.,
1992). The expression of BDNF in
hippocampal neurons is strongly
increased by physiological and
pathophysiological levels of neuronal
activity (Zafra et al., 1990; Ernfors et al.,
1991; Isackson et al., 1991) providing a
positive feedback on synaptic function
and protecting neurons from
excitotoxicity (Lessmann et al., 2003).
NGF expression shows very small
changes during postnatal development
(Ernfors et al., 1990), except in the
hippocampus. Expression of NT-4/5 is
prominent postnatally in hippocampus,
neocortex, cerebellum and thalamic
nuclei, and continues to be expressed
until adulthood (Friedman et al., 1998).
Alterations in neurotrophin levels
have profound effects on a wide variety of
phenomena, including myelination,
regeneration, pain, aggression,
depression and substance abuse
(reviewed in Chao, 2003). The biological
properties of the neurotrophins have been
analyzed in animals with deletions in
their neurotrophin genes. Since complete
lack of neurotrophins results in death
early after birth, with the only exception
of NT-4/5 (Conover et al., 1995), the
alterations in brain function and
behaviour have been analyzed in
heterozygous mice. NGF+/- mice show
decreased cholinergic innervation of the
hippocampus and deficiencies in memory
(Chen et al., 1997), together with a
profound reduction of neurons of the
peripheral nervous system (Crowley et
al., 1994). Behavioural tests on the
BDNF+/- mice show that these mice are
aggressive, hyperphagic and obese
(Lyons et al., 1999; Kernie et al., 2000;
Rios et al., 2001) and present impairment
in spatial memory consistent with defects
in hippocampal long-term potentiation
(Korte et al., 1995; Patterson et al., 1996;
Bartoletti et al., 2002). They also display
elevated striatal dopamine levels (Dluzen
et al., 2001), and reduction of neurons
and mechanoreceptors in the peripheral
nervous system (Ernfors et al., 1994a;
Carroll et al., 1998). The latter is also
observed in the NT3+/- mice (Airaksinen
et al., 1996, Ernfors et al., 1994b).
Additionally, BDNF+/- mice are deficient
in amygdala kindling activity (Elmer et
al., 1997) and present abnormal
cardiovascular development (Donovan et
al., 1996). NT-4/5- deficient mice are
long-lived and show no obvious
neurological defects (Conover et al.,
1995) Overall, these phenotypes show
that neurotrophins have essential
functions for the developing and mature
vertebrate nervous system as well as for
some non-neuronal functions.
1.1.1.2 Neurotrophin receptors
To exert their biological actions,
neurotrophins interact dually but with a
different binding affinity with two types
of receptors: the Trk receptors, and a
tumor necrosis factor receptor like
molecule, p75NTR (reviewed in Huang and
Reichardt, 2003). While all neurotrophins
display low affinity binding with p75,
their interaction with Trk receptors is
more specific with NGF activating TrkA,
BDNF and NT-4/5 activating TrkB, and
Review of the Literature
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7NT3 activating TrkC (see Trk receptors
section). As described above, the mature
form of a neurotrophin displays high
affinity interaction with its Trk receptor
and normally a low affinity interaction
with p75 NTR. On the contrary, the pro-
form of a neurotrophin exerts high
affinity binding to p75 NTR while it binds
poorly to the Trk receptor. This dual
binding system enables mature and
immature neurotrophins to activate
opposing pathways mediating opposing
cellular functions, e.g. survival and death
signals (Dechant, 2001; Miller and
Kaplan, 2001; Roux and Barker, 2002).
Nevertheless, different cellular responses
to neurotrophins are not exclusively
generated by differential ligand-receptor
interaction with different signaling
cascades coupled to the receptors
involved. Modification by dynamic
cellular processes such as changes in the
lipid environment, internalisation into
intracellular compartments, retrograde
transport, and differential processing of
the signaling endosomes are also
involved, and currently under extensive
study (reviewed in Dechant, 2001;
Heerssen and Segal, 2002).
Trk receptors
A chimeric oncogene found in human
colon carcinoma consisting of the fusion
of a truncated tropomyosin and a protein
tyrosine kinase sequences, and the
Review of the Literature
Fig. 2. Schematic structure of mammalian neurotrophin receptors and consequences of re-
ceptor-ligand binding. Full-length Trk receptors (FL) contain an extracellular domain con-
sisting of three leucine-rich repeat (LRR) motifs separated by two cystein rich clusters (C1-
2), and two inmunoglobulin-like domains (Ig1-2). The intracellular domain contains tyrosine
kinase domains (TK). Different isoforms show deletions/insertions in their extracellular or
intracellular structures (S, short-length receptors; TK, truncated receptors; KI, receptors with
insertions). The p75NTR contains four extracellular cystein-rich repeats (CR1-4) and an intra-
cellular “death” domain (DD). S-p75 lacks CR1-CR3. B) NT binding to Trk receptors acti-
vates signal transduction pathways that induce neuronal survival and growth, whereas NT
binding to p75NTR induces cell death signals. Some intracellular signaling pathways are indi-
cated. MAPK, mitogen-activated protein kinase; PI3K, phosphatidylinositol 3-kinase; PLCγ,
phospholipase-Cγ; JNK, Jun N-terminal kinase.
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8respective proto-oncogene, were cloned
by Martin-Zanca and collaborators
(Martin-Zanca et al., 1989).
Consequently the proto-oncogene was
named tropomyosin-related kinase (Trk)
and is now commonly referred to as
TrkA. The TrkB and TrkC genes were
identified by the virtue of their high
homology to TrkA (Huang and Reichardt,
2003). There are three neurotrophin Trk
receptors, TrkA, TrkB and TrkC, which
bind neurotrophins with specific
selectivity. NGF binds to TrkA (Kaplan et
al., 1991; Klein et al., 1991), BDNF and
NT-4/5 bind to TrkB (Klein et al., 1989;
Klein et al., 1990), and NT-3 to TrkC
(Lamballe et al., 1991;). NT-3 is,
although less efficiently, also able to
activate each of the other Trk receptors
(reviewed in Huang and Reichardt, 2001).
In addition, all neurotrophins bind to the
pan-neurotrophin receptor p75NTR (see
explanations below and Fig. 2).
Structurally, all Trk receptors are
members of the transmembrane receptor
tyrosine kinase superfamily. They have an
extracellular domain that contains
leucine-rich motifs flanked by cystein
clusters and IgG-like domains at the
juxtamembrane region that are
responsible for neurotrophin binding. The
intracellular tyrosine kinase domain
becomes activated upon NT binding. As
a first step of this activation, ligand
binding to the extracellular domain
causes two Trk monomers to dimerize,
thereby bringing the two intracellular
tyrosine kinase domains into close
contact to each other.
Binding of neurotrophins to Trk
receptors causes dimerisation and
autophosphorylation of intracellular
tyrosine residues that act as docking sites
for adaptor proteins, such as the src
homology 2 domain containing trans-
forming protein/FGF receptor substrate 2
(Shc/FRS-2), and to phospholipase-Cγ
(PLCγ) (reviewed in Patapoutian and
Reichardt, 2001; Huang and Reichardt,
2003. See Fig. 3 and 4). Subsequently to
ligand binding, the activated receptors
initiate several signal transduction
cascades. Binding to Shc or FRS-2 can
lead to activation of the Ras-ERK and
phosphatidylinositol-3-OH kinase
(PI3K)/Akt pathways, whereas binding of
PLCγ  leads to mobilization of Ca2+ from
internal stores and other downstream
effects.  To mention some examples, the
phospholipase activity of PLC-γ1 plays
an essential role in nerve growth factor
(NGF)-triggered Raf/MEK/MAPK
pathway activation in PC12 cells (Rong et
al., 2003), and in vivo experiments in
mutated mice have shown that a
consequence of BDNF-triggered TrkB
signaling in neurons is the activation of
the transcription factor cAMP response
element-binding protein (CREB;
Finkbeiner et al., 1997; Minichiello et al.,
2002; Huang and Reichardt, 2003).
Alternative splicing has been
described for all Trk receptors. Trk A and
TrkB transcripts are alternatively spliced
at a small exon encoding their
extracellular domain (Garner et al., 1996;
Strohmaier et al., 1996). Receptor
isoforms for TrkB (TrkB.T1-2) and TrkC
(TrkC.TK1-5) may have truncations or
insertions in the intracellular tyrosine
kinase domains (Klein et al., 1990;
Lamballe et al., 1993; Middlemas et al.,
1991). A summary of different isoforms
of NT receptors is presented in Figure 2.
The functions of the isoforms are not
completely known but evidence supports
their importance in affecting the
specificity of the responsiveness of Trk to
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receptors may modify local effective NT
concentration by capturing and
presenting NT to neurons expressing full-
length Trk receptors, inhibit activation of
Trk kinases by forming non-productive
heterodimers, regulate the surface
expression of full-length receptors, and
modify the substrate specificity altering
cellular responses to their activation (for
review see Roux and Barker, 2002;
Huang and Reichardt, 2003). Activation
of these pathways will culminate in the
activation of transcription factors that
affect gene expression and consequently
modulate cell growth and survival of
many neuronal populations (Patapoutian
and Reichardt, 2001; Huang and
Reichardt, 2003).
p75NTR
Each neurotrophin binds to the
transmembrane pan-neurotrophin
receptor p75NTR, a related member of the
tumor necrosis factor receptor
superfamily (reviewed in Hempstead,
2002). In the CNS, p75NTR is expressed in
a wide variety of cell populations during
embryonic stages, whereas postnatally,
the levels are reduced in most areas
(reviewed in Roux and Barker, 2002).
A mature p75NTR is a 399-aminoacid
transmembrane receptor that contains
four (1-4) cystein-rich repeats in the
extracellular domain (ECD) (Fig.2). The
third extracellular domain is responsible
for the interaction with neurotrophins
(reviewed in Roux and Barker, 2002). The
intracellular juxtamembrane domain
contains regions likely to mediate
interactions with multiple p75NTR adaptor
proteins involved in biological activities
comprising death and survival, cell cycle,
axonal elongation and synaptic
transmission (reviewed in Dechant and
Barde, 2002). The C-terminal domain
that contains a globular “death” domain
(Liepinsh et al., 1997) is implicated in the
transduction of cell death signals
(reviewed in Roux and Barker, 2002).
Both domains present post-translational
modifications with yet unknown
functions, although roles in protein-
protein interaction, intracellular receptor
folding and cellular localization of the
p75NTR receptor have been suggested
(reviewed in Roux and Barker, 2002).
Alternative splicing of the p75NTR
results in a short isoform (S-p75) that
lacks the NT-binding domain 1-3
(reviewed in Dechant, 2001). The
physiological role of this splice variant is
currently unknown (Dechant, 2001). A
recent report shows the existence of a
homologous gene, NRH2, which encodes
a protein structurally similar to the short
form of p75NTR, which regulates NGF
binding to TrkA (Murray et al., 2004).
Further modifications of the full-length
p75NTR receptor have been reported to
occur at the posttranslational level. They
include cleavage of the receptor by
metalloproteinases (DiStefano et al.,
1993) generating a soluble extracellular
domain that is capable of binding
neurotrophins, and a remaining truncated
transmembrane domain. This
modification is predominantly observed
during development and following
peripheral nerve injury, but its biological
role, however, has remained elusive
(reviewed in Roux and Barker, 2002).
Analysis of the ablation of p75ntr (von
Schack et al., 2001) has recently revealed
that mice lacking p75NTR phenotypically
present severe defects in both nervous and
vascular system (von Schack et al., 2001).
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By using a different set of adaptor
proteins than Trk receptors, p75NTR is able
to promote both survival and apoptosis in
different cells as well as affect axonal
growth (Huang and Reichardt, 2001) after
neurotrophin binding. The death inducing
capacity of p75NTR has been attributed to
its ability to activate effectors such as
proteases of the caspase family, p53,
ceramides and Jun N-terminal kinase
(JNK) signaling cascade (Aloyz et al.,
1998; Yoon et al., 1998 Agerman et al.,
2000; Troy et al., 2002; Huang and
Reichardt, 2003). On the contrary, pro-
survival pathways activated by p75NTR
include NF-κΒ and Akt (Wooten et al.,
2001; Roux and Barker, 2002. See Fig.
3).
In addition to its ability to act as an
independent receptor coupled to its own
signaling apparatus, p75NTR has also been
shown to modulate the affinity and
signaling of Trk receptors. The
association with p75NTR modulates
affinity and ligand specificity of Trk
receptors (Chao, 2003). Initial binding
and transfection studies revealed that
p75NTR bound NGF with low-affinity. The
receptor was, therefore, termed ‘low
affinity NGF receptor’ (LNGFR; Chao et
al., 1986; Johnson et al., 1986; Radeke et
al., 1987), but later and coincident with
the discovery of the other neurotrophin
family members it was shown that p75 NTR
binds all neurotrophins with
approximately equal affinity (reviewed in
Huang and Reichardt, 2003). A recent
report by Lee and co-workers (2001)
demonstrated that the recombinant,
cleavage resistant NGF precursor,
proNGF, binds p75NTR with high-affinity
and induces p75NTR-dependent apoptosis
of sympathetic neurons in culture,
suggesting that neurotrophins may
activate p75NTR in both pro-and mature
forms (Lee et al., 2001; Hempstead,
2002). In this scenario, the mature form
of the neurotrophins preferentially binds
to and activates the Trk receptor while the
pro-form aims at the p75NTR receptor
(Fig.3). Indeed, proNeurotrophins are
secreted as p75NTR ligands in vivo
inducing p75NTR -mediated death in
damaged neurons (Harrington et al.,
2004). Whether proNeurotrophins play a
role during development is unknown.
Review of the Literature
Fig. 3. Schematic represen-
tation of the binding of
neurotrophins to their recep-
tors. All immature (pro)
neurotrophins bind to
p75NTR with high aff inity
(bold ar rows). Mature
neurotrophins bind to both
p75NTR and Trk receptors,
but with higher affinity to
Trk. NGF binds TrkA,
BDNF and NT-4/5 bind to
TrkB, and NT-3 preferen-
tially binds to TrkC but can
activate all the Trks (indi-
cated with dashed arrows).
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Recently, the work by Nykjaer and
colleagues (Nykjaer et al., 2004)
indicated that proNGF induces cell death
through binding p75NTR only when it is
forming a complex with Sortilin, a
protein that acts as a neurotensin receptor
(Mazella, 2001). Further studies are
needed to show whether other pro-
neurotrophins use a similar, cleavage-
dependent mechanism to target ligands
derived from one precursor to different
receptors. It will also be important to
determine the role of these ligands, as
independent effectors, or potentially as
dominant negative modulators for mature
neurotrophin functions.
Cross-talk with other membrane
receptors and non-neurotrophin ligands
Beyond cell death and survival, Trk and
p75NTR have been shown to promote other
effects by binding to non-neurotrophin
ligands or other membrane receptors. For
instance, recent studies indicate that by
modulating Rho activity (Yamashita et
al., 1999), p75NTR is able to associate with
certain gangliosides (Yamashita et al.,
2002) and interact with membrane
proteins such as the Nogo receptor
(NgR1; Wang et al., 2002), as well as
with the recently identified
transmembrane protein LINGO-1 (Mi et
al., 2004) in order to regulate axon
elongation. Additionally, the p75NTR also
binds non-neurotrophin ligands such as
the neurotoxic prion protein fragment PrP
(101-126) (Della-Bianca et al., 2001), the
Ab-peptide of the amyloid precursor
protein (APP; Kuner et al., 1998; Perini
et al., 2002), a rabies viral capsid
glycoprotein (RV-Gs; Tuffereau et al.,
1998) and a mollusan cystein-rich
neurotrophic factor (CRNF; Fainzilber et
al., 1996). In this context, it has been
suggested that p75NTR may be a promising
drug target for preventing cell death and
activating axonal elongation (reviewed by
Dechant and Barde, 2002).
Trk receptors also display cross talk
with other membrane receptors. For
instance, TrkB activation upon BDNF
binding increases the ion influx through
transient receptor potential (TRP) ion
channel TRPC3 (Li et al., 1999). This
channel is highly expressed in brain
regions where TrkB receptors are found,
and their expression is especially
abundant during neonatal development
suggesting a role in neurotrophin-
dependent plasticity of this type of
receptors. Another example of interaction
between Trk and TRP channels is the
TRPV1 channel or capsaicin receptor
(Bonnington and McNaughton, 2003).
These channels are activated by heat or
capsaicin, and NGF is known to
potentiate the response of nociceptive
sensory neurons to capsaicin. Mice
lacking TRPV1 have a reduced
nociceptive sensitization when injected
with NGF. In addition, in NGF-
responsive neurons, TrkA and TRPV1 are
frequently co-expressed, and co-
immunoprecipitation studies indicated
that TRPV1, TrkA and PLCγ associate to
form a complex that results in the
activation of the channel after NGF
application (Bonnington and
McNaughton, 2003).
Furthermore, electrophysiological
measurements in the hippocampus have
shown that BDNF is also able to suppress
the activity of AMPA receptor-mediated
currents. This indicates that BDNF may
regulate glutamatergic transmission at
primary afferent synapses and implies a
possible close association between TrkB
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and AMPA receptors (Balkowiec et al.,
2000). Additionally, the recent work by
Blum and collaborators (Blum et al.,
2002) showed that in both cell lines and
hippocampal neurons, the voltage-gated
sodium channel Na
V
1.9, is activated by
BDNF/TrkB binding, since an inward
sodium current detected after BDNF
application was prevented by activity
blockers and Trk-specific inhibitors, and
by blocking the expression of the
channel. This work is providing
molecular basis for the understanding of
neurotrophin-evoked excitation in the
CNS (i.e. see Kafitz et al., 1999).
Although the mechanisms for receptor-
ion channel interactions are unknown,
conformational changes in the structure
of Trk are suspected to be the cause
(reviewed in Chao, 2003). The biological
consequences of the Trk interactions with
ion channels are yet unknown. Further
analysis on the molecular mechanisms
underlying these interactions, i.e. in
transgenic animals, may contribute to our
understanding of the ability of
neurotrophins to regulate synaptic
plasticity in adult brain.
Another type of cross-talk observed
between Trk receptors and other
membrane proteins are the transactivation
of Trk receptors by G-protein-coupled
(GPC) ligands such as adenosine and the
pituitary adenylate cyclase-activating
polypeptide (PCAP) (Lee et al., 2002).
PACAP can exert trophic effects through
a mechanism involving Trk receptors and
utilization of tyrosine kinase signaling.
These interactions result in
neuroprotection, and suggests an
explanation for the several
neuroprotective actions of PACAP upon
neuronal populations after injury, nerve
lesion, or neurotrophin deprivation (Lee
et al., 2002).
The GDNF-family ligand (GFL)
tyrosine kinase receptor, c-Ret
(Airaksinen and Saarma, 2002) is another
of the transmembrane receptor that has
been shown to be activated by NTs.
Surprisingly, binding of NGF to TrkA
results in the activation of c-Ret without
the requirement of GFL ligand binding,
promoting survival in sympathetic
neurons (Tsui-Pierchala et al., 2002) and
representing a new mechanism for
transmitting survival signals within
neurons.
Overall, these current data indicate
that neurotrophin-mediated activation of
neurotrophin receptors leads to a variety
of biological responses, which includes
proliferation, survival, and axonal and
dendritic growth, but also assembly and
remodeling of cytoskeleton, membrane
trafficking, and modification of synaptic
functions.
1.1.2 Functional roles of neurotrophins
1.1.2.1 Role of neurotrophins and their
receptors in neuronal activity and
synaptic plasticity
One of the most significant developments
in the neurotrophin field has been the
realization that these proteins and their
receptors are modulated by neuronal
activity and are involved in synaptic
transmission and plasticity (Schinder and
Poo, 2000). Experimental evidence so far
strongly indicates that neuronal activity
regulates synthesis, secretion and
signaling of NTs, thus modifying
synaptic transmission and connectivity as
a consequence of specific changes in the
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pre- and postsynaptic neurons (Schinder
and Poo, 2000).
Studies on hippocampal slices and
cortical neurons have shown that the
levels of transcripts of NTs and their
receptor genes, specially those encoding
for NGF, BDNF and TrkB, are elevated in
epileptogenic situations and after
pharmacological modulation of
glutamatergic receptor activation (Gall
and Isackson, 1989; Zafra et al., 1990;
Ernfors et al., 1991; Lauterborn et al.,
2000). Elevation of NT expression after
electrical stimulation has been also
reported in the visual cortex (Castrén et
al., 1992), and the peripheral nervous
system (Wang and Poo, 1997). Not only
the expression but the secretion and
release of NT is regulated by neuronal
activity. In hippocampal slices or
dissociated cell cultures, robust
depolarization (e.g. in response to high
KCl, glutamate or patterned electrical
stimulation) results in an elevated level of
secreted and/or surface-bound NTs
(Blöchl and Thoenen, 1995; Goodman et
al., 1996; Balkowiec and Katz, 2000).
Moreover, NTs themselves can also
function as a regulatory signal for NT
secretion (BDNF: Canossa et al., 1997;
NGF: Kruttgen et al., 1998). The
secretion is mediated by an elevation of
intracellular calcium in response to
neurotrophin receptor signaling or by
direct membrane depolarization induced
by the NTs (reviewed in Lessmann et al.,
2003).
Neuronal activity also modifies
synaptic strength (i.e. synaptic plasticity).
It is thought that this phenomenon is the
basis of the formation of memory traces
in the brain, and that neurotrophins are
involved in these processes. Indeed, NTs
have profound effects on several
signaling pathways in CNS neurons,
which are necessary for the induction and
maintenance of long-term changes in
synaptic strength such as long-term
potentiation (LTP) (Thoenen, 1995;
McAllister et al., 1999; Poo, 2001). LTP
experiments (few seconds of high-
frequency stimulation which enhances
synaptic transmission in the hippocampus
for days or even weeks) have
demonstrated that synaptic plasticity
results from the activation of cell surface
receptors or ion channels that activate
signaling systems coupled to the
transcriptional machinery in the nucleus
(reviewed in Poo, 2001). In this context,
the role of BDNF and TrkB in LTP has
been established (Korte et al., 1995;
Patterson et al., 1996; Minichiello et al.,
1999), and recently, the creation of mice
strains carrying a mutation in the
intracellular domain of TrkB (Minichiello
et al., 2002) have been the key for
demonstrating that phospholipase-Cγ
(PLCγ) is the intracellular cascade
involved in plasticity-related effects of
BDNF in the hippocampus (Minichiello
et al., 2002; Ernfors and Bramham, 2003;
Fig. 4).
1.1.2.2 Role of neurotrophins in
pathophysiological conditions
The concept that neurotrophin expression
in the brain is modulated in response to
neuronal activity was first suggested by
the demonstration of increased NGF
mRNA levels following recurrent limbic
seizures (Gall and Isackson, 1989). Sub-
sequent studies demonstrated that the ex-
pression of NGF, BDNF and NT-3
mRNAs is drastically altered following
seizures in response to electrolytic lesions
(Isackson et al., 1991; Rocamora et al.,
Review of the Literature
thesis.pmd 24.5.2004, 14:2713
14
1992; Rocamora et al., 1994), kindling
(Ernfors et al., 1992) or kainic acid injec-
tion (Dugich-Djordjevic et al., 1992;
Wetmore et al., 1994). The up-regulation
of BDNF and the activation of Trk recep-
tors in the context of seizures appear to
play a key role in the development of hy-
perexcitability in vitro and in vivo (Binder
et al., 2001).
In addition to seizure induction, other
pathological conditions that clearly result
in neuronal damage, such as mechanical
injury, ischemia and hypoglycemia, also
result in altered neurotrophin expression,
and their low (Harrington et al., 2004) or
high-affinity receptors, TrkB and TrkC
(Lindvall et al., 1994). These damage-
induced changes are thought to protect
neurons undergoing acute metabolic
stress after an insult and to stimulate
sprouting and synaptic reorganization in
the period of recovery.
Animal-models for neurodegenerative
diseases such as Alzheimer’s and
Parkinson’s diseases and amyotrophic
lateral sclerosis (ALS), also demonstrate
alterations in neurotrophin expression
(reviewed in Dechant and Barde, 2002).
For instance, in the adult brain, p75NRT is
re-expressed under various pathological
conditions, including epilepsy, axotomy
and neurodegeneration. The levels of re-
expression are comparable to those seen
during early development. This suggests
that an imbalance of neurotrophin
receptor signaling may be involved in
diseases of the nervous system, or that the
disease may induce a switch to a
developmental expression of this receptor
(Rende et al., 1993; Kokaia et al., 1998;
Fig. 4. Schematic representation of the signaling pathways associated with the Shc- and phos-
pholipase-Cγ (PLCγ)-adaptor binding sites of TrkB [Tyr 515 (Y515) and Tyr 816 (Y816),
respectively]. ERK, extracellular-signal regulated kinase; CREB, cAMP-response-element-
binding protein; CaMKIV, Ca2+-calmodulin-dependent kinase IV; PLCγ, phospholipase-Cγ;
DAG, Diacylglicerol; IP3, Inositol 1,4,5-phosphate; PI3K, phosphatidylinositol 3-kinase
(adapted from Ernfors and Bramham, 2003).
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Mufson and Kordower, 1992; Giehl,
2001; Lowry et al., 2001; Dechant and
Barde, 2002). Furthermore, it has
recently been discovered that a single
amino-acid (Val 66 Met) polymorphism
in the pro-domain of BDNF accounts for
the ability of BDNF to undergo proper
secretion and results in memory deficits
(Egan et al., 2003). These findings
associate functional NT directly with
psychiatric disorders.
1.1.2.3 Role of neurotrophins in
corticospinal survival mechanisms
Corticospinal neurons (CSN) develop
from subplate cortical precursors after
embryonic day 13 (Armand et al., 1994).
Already during migration to their final
destination, neocortical layer V, CSN
extend axonal processes to subcortical
targets. As CSN maturate, they maintain
the collateral to their primary target, the
spinal cord, and eliminate collaterals to
the intermediate targets, e.g. the optic
tectum (Armand et al., 1994). During
embryonic and early postnatal
development, all target areas of CSN
express the neurotrophins BDNF, NT-4/5
and NT-3, together with other
neurotrophic factors such as CNTF and
GDNF (reviewed in Giehl, 2001). During
embryonic stages of development,
however, the fate of cortical neurons is
mainly determined by local signals. In this
context, endogenous NT-3 acts as a
differentiation signal for cortical
precursors to develop into a neuronal
phenotype (Ghosh and Greenberg, 1995)
that depends on autocrine/paracrine
BDNF supply for survival (reviewed in
Giehl, 2001). The role of those
neurotrophic factors that are expressed in
the primary and intermediate target areas
of developing CSN is unknown.
Mature CSN are located in layer V of
the cortex, in areas associated with motor
function (Miller, 1987; Nudo and
Masterton, 1990). Virtually all adult CSN
express TrkB and TrkC, and most of them
also the GDNF receptor GFRα1 (Giehl et
al., 1998) and the CNTF receptor
CNTFRα1 (Lee et al., 1997). As
suggested by in vitro studies (Giehl et al.,
2001), CSN appear to shift trophic
dependencies during postnatal
development from being dependent on
BDNF (Ghosh and Greenberg, 1995) to
other survival factors, CNTF, GDNF and
NT-4/5 (Junger and Varon, 1997; Junger
and Junger, 1998).
To study trophic dependencies in adult
CSN, Giehl and collaborators (Giehl and
Tetzlaff, 1996; Bonatz et al., 2000)
developed an in vivo model in which cell
death of CSNs is induced by axotomy at
internal capsule level (ICL). CSNs are
specifically labeled by injecting
retrograde tracers to the corticospinal
tract of the spinal cord (Bonatz et al.,
2000). Once traced, axotomy of CSNs is
stereotactically induced at the level of the
internal capsule and analysis of survival
can be assessed in CSNs of the
sensorimotor cortex (Bonatz et al., 2000).
Intracortical infusions to the injured
neurons serve to identify growth factors
that might be relevant for the trophic
support of CSN (Fig.5)
Accordingly, it has been shown that
after injury BDNF is essential for the
survival of CSN since application of
function-blocking BDNF antibodies
results in severe death of axotomized
CSN, whereas exogenous application of
BDNF results in total rescue of CSNs
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(Giehl et al., 1998). Axotomized CSNs
are supported via a paracrine BDNF-
mechanism that can be stimulated by
BDNF- and NT-3 (Schutte et al., 2000;
reviewed in Giehl, 2001). GDNF is also
a survival factor for lesioned CSN (Giehl
et al., 1997), and its survival effect
depends on the presence of endogenous
BDNF (Giehl et al., 1998). In contrast to
NT-3, GDNF does not exert its effect via
stimulation of cortical BDNF expression
(Schutte et al., 2000). Inhibition of
endogenous NT-3 and its TrkC or p75NTR
receptor has been shown to promote
CSNs survival, suggesting that
endogenous NT-3 is responsible for the
demise of a significant portion of injured
CSNs. Even more, p75NTR is strongly
induced in lesioned CSNs (Giehl et al.,
2001; Harrington et al., 2004) while it is
barely detectable in the unlesioned
neurons. Consistently, blockade of p75NTR
or neutralization of a p75NTR binding
ligand, proNGF, rescues CSNs from
axotomy- induced death. This indicates
that in addition to TrkC/NT-3, also the
p75NTR/proNGF pathway promotes the
death of lesioned CSNs. A schematic
representation of the trophic dependences
of CSNs is depicted in Fig. 6.
Recently, cortical neurons from the
layer V have been shown to express the
chloride cotransporter KCC2 (Kanaka et
al., 2001). As CSNs are a major
subpopulation of this layer, this finding
suggests that CSNs are a suitable model
for studying possible relationships
between NTs and chloride homeostasis.
1.2 CHLORIDE HOMEOSTASIS IN BRAIN
DEVELOPMENT AND PATHOPHYSIOLOGY
1.2.1 GABA and neuronal maturation
In the late 50’s David Curtis and John
Watkins were the first to show that γ-
aminobutyric acid (GABA) inhibits the
ability of mammalian neurons to fire
Fig. 5. Tracing and lesion of CSNs. A) To distinguish CSNs from other cortical layer V CSNs,
neurons are retrogradely labeled by fluorescence tracer injections to the corticospinal tracts at
cervical spinal cord levels C4/5. Fast blue (FB) is applied before lesion. B) After tracing,
CSNs of one side of the brain are axotomized by unilateral internal capsule lesion (ICL) and
the extension of the damage is controlled by the injection of rhodamine (RDX) immediately
after lesion. This lesion results in axotomy of all corticospinal neurons of the sensory motor
cortex of the lesion side. Osmotic minipumps are implanted intraparenchymally and con-
nected to a steel cannula in the same operation session for intracortical delivery of solutions.
C) Extension of the lesion (modified from Giehl and Tetzlaff, 1996 and Bonatz et al., 2000;
with permission)
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action potentials (Curtis et al., 1959). To
date, it is of a general knowledge that
most inhibitory neurons in the brain and
spinal cord use either GABA or glycine
as inhibitory transmitters, compensating
the effects of excitatory transmitters (i.e.
glutamate) and therefore generating
inputs essential for the proper electric
activity in the brain.
GABA, which is produced mainly
through enzymatic decarboxylation of
glutamic acid by glutamic acid
decarboxylase (GAD), binds to two types
of receptors, named GABA
A
 and GABA
B
.
GABA
A
 is a ligand-gated ion channel
permeable to anions, and GABA
B
 is a
metabotropic receptor that by G protein
transduction will open channels
permeable to K+ or inhibit channels
permeable to Ca2+ (for review see Kaila,
1994).
GABA
A 
receptors are highly
permeable to chloride (Cl-). When
GABA
A
 receptors are open, outward/
inward currents of Cl- may enter or leave
the cell shifting the membrane potential
Fig. 6. Trophic dependencies of corticospinal neurons (CSNs). Cortical precursors require
the presence of basic Fibroblast Growth Factor (bFGF) to proliferate and NT-3 to differenti-
ate into a corticospinal phenotype. Survival of CSNs at embryonic stage is dependent on
BDNF. Early postnatal CSNs lose BDNF-dependency to other survival factors such as GDNF,
CNTF and NT-4/5. Death-promoting factors of CSNs at embryonic and early postnatal stages
are unknown. Adult CSNs only require BDNF for survival when lesioned. The factors that
promote survival/death of intact adult neurons are not known. The survival of adult CSNs
depends on BDNF-mediated signaling through TrkB only under pathological conditions, and
the death of injured neurons is promoted by the proNGF and NT-3, when binding to p75NRT
and TrkC respectively. The factors that promote survival/death of intact adult neurons are not
known.
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close to the reversal potential for Cl- (E
Cl
)
(Kaila 1994). Additionally, GABA
A
receptors are permeable to bicarbonate
(HCO
3
- ), as demonstrated by Kaila and
collaborators (Kaila, 1994) when
studying the effect of GABA
A
-mediated
responses on pH regulation in dissociated
and cultured hippocampal neurons
(Pasternack et al., 1993) and in crayfish
muscle fibers (Kaila and Voipio, 1987;
Kaila et al., 1992). Thus, the reversal
potential of GABA
A
 receptors (E 
GABA-A
)
is set by E 
Cl 
 and E 
HCO3.
 Therefore, not
only changes in intracellular chloride
concentrations [Cl-]
i
 but also in
intracellular bicarbonate concentrations
[HCO3-]
i
 determine the polarity (hyper-
or depolarizing) of the GABA
A
-mediated
response.
GABA
A
 receptor-mediated responses
vary during development. The well-
known inhibitory synaptic actions of
GABA occur in postnatal and mature
neurons. At this stage and under normal
conditions, GABA
A
 receptor-mediated
responses are hyperpolarizing
(inhibitory). On the contrary, in immature
neurons GABA
A
 receptor-mediated
responses are depolarizing (excitatory)
and facilitate the generation of Na+ and
Ca2+ currents which will induce the
activation of voltage-dependent Ca2+
channels (VDCCs) consequently
generating [Ca2+]i transients that have a
central role in neuronal differentiation,
growth and maturation (Yuste and Katz,
1991; Barker et al., 1998; Maric et al.,
2001; Owens and Kriegstein, 2002). This
shift in GABAergic responses involves
developmental and maturation processes
tightly related to the expression and
function of cation-chloride cotransporters
(CCC).
1.2.2 Cation Chloride
Cotransporters
CCCs are a group of proteins that
participate in ion homeostasis and have
lately been discovered to be intrinsically
involved in mechanisms that control
neuronal growth and maturation, synaptic
development and plasticity,
neuroendocrine functions and the
generation of network rhythms (reviewed
in Lauf and Adragna, 2000; Payne et al.,
2003).
Their nature is electroneutral and as
such, they do not generate any current.
Instead, they contribute to the inwardly or
outwardly directed net flux of ions
generated by gradients that are set by
active transporters such as the Na+/K+-
ATPase (see Fig.7). The hydrolysis of
ATP by the Na+/K+-ATPase generates an
inward gradient of K+ and an outward
gradient of Na+ that by the action of
CCCs will influence the net movement of
Cl-. Consequently, under physiological
conditions, the gradient of K+ is
employed by the K+/Cl- cotransporters
(KCC) to extrude Cl- out of the cell,
whereas the Na+/K+/2Cl- cotransporters
(NKCC) will use the gradient of Na+ to
induce an increase of the intracellular Cl-
concentration. Together with the action of
other secondarily active transport
proteins, the Na+-dependent and
independent anion exchangers (NDAE
and AE, respectively), which exchange
Cl- for HCO3-, changes in the
intracellular concentration of Cl- will
influence the overall electrochemical
gradient of Cl- and hence the resulting
hyperpolarizing or depolarizing current
across anion-permeable channels (i.e.
GABA- and glycine-gated ion channels)
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(reviewed in Kaila, 1994; Payne et al.,
2003) (Fig.7).
To date, seven electroneutral cation-
Cl- cotransporters have been described in
mammals: one Na+/Cl- cotransporter
(NCC), two Na+/K+/2Cl- cotransporters
(NKCC1 and NKCC2) and four K+/Cl-
cotransporters (KCC1-4). Structurally,
they are 120-200 kDa glycoproteins with
a relatively small intracellular N terminus
followed by 12 putative transmembrane
segments, and a large intracellular C
terminus, which in the case of KCC1 and
KCC2 presents a tyrosine kinase
consensus site (Payne et al., 1996).
The KCC1 isoform was the first
CCCs discovered (Gillen et al., 1996). It
is activated by cell swelling and
considered to be the house-keeping
transporter that maintains volume
homeostasis in all cells (Gillen et al.,
1996; Holtzman et al., 1998; Gillen and
Forbush, 1999). The two isoforms
NKCC1 and KCC1 are ubiquitously
expressed in all tissues (Gillen et al.,
1996; Plotkin et al., 1997). NCC and
NKCC2 are essentially restricted to the
kidney (Russell, 2000), KCC3 and KCC4
are found in both CNS and non-neuronal
tissues (Hiki et al., 1999; Mount et al.,
1999; Race et al., 1999) and KCC2 is
only expressed in neurons (Payne et al.,
1996; Rivera et al., 1999; for review see
Lauf and Adragna, 2000; Payne et al.,
2003).
There is a tight correlation between
the expression of some CCCs and
changing levels of intracellular Cl- during
development (Li et al., 2002). In that
context, the cotransporters NKCC1 and
KCC2 have a central role in the
regulation of chloride homeostasis in
neurons. For instance, the expression of
NKCC1 is high during early postnatal
development (Plotkin et al., 1997; Lu et
al., 1999; Li et al., 2002). Therefore,
Fig. 7. Cathion Chloride transporters and their basic modes of operation. Under physiologi-
cal conditions, NKCCs and AEs co-transporters mediate Cl- uptake, whereas KCCs and NDAEs
extrude Cl-. The Na+/K+-ATPase generates a K+ gradient that is employed by KCCs to extrude
Cl-.This results in an inwardly directed electrochemical gradient for Cl- that generates hyper-
polarizing currents across anion-permeable channels. Uptake of Cl- by NKCCs is driven mainly
by the energy taken from the Na+ gradient, and the resulting outwardly directed Cl- electro-
chemical gradient permits depolarizing Cl- currents (modified from Payne et al., 2003).
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during developmental processes in
immature neurons and in adult sensory
neurons, the depolarizing GABAergic
activity is regulated by NKCC1, raising
the internal Cl-. On the contrary, KCC2
expression increases during development
(Lu et al., 1999), thus, the inhibitory
GABA responses in mature CNS neurons
are regulated through KCC2 by lowering
the [Cl-]i 
 
(Lu et al., 1999; Rivera et al.,
1999; Hubner et al., 2001; Li et al., 2002;
reviewed in Payne et al., 2003)
The wide variety of physiological
roles performed by the CCCs have been
analyzed by gene disruption of the
different transporters in mouse, and the
phenotypes observed have been in some
cases linked to human diseases.
Summarizing, NCC, NKCC1 and
NKCC2 may have an important role in
regulating hypertension, KCC2 in
epilepsy, KCC1 and KCC3 in
hemoglobinopathies, and KCC4 in
hearing disorders (Boettger et al., 2002;
reviewed in Delpire and Mount, 2002).
However, the precise role of the
individual pathways involved in the
regulation of these phenotypes are yet
unknown.
1.2.3 KCC2
1.2.3.1 Neuronal expression of KCC2
Identified using a combination of
database searching, Polymerase Chain
Reaction (PCR) techniques and cDNA
library screening, KCC2 was
characterized as a ~145 kDa protein with
an amino acid sequence 67% identical to
KCC1 (Payne et al., 1996; Williams et
al., 1999). When comparing the primary
structures of KCC1 and KCC2, the
predicted structure for KCC2 is a
glycosylated 12 transmembrane (TM)
domains protein where TM2 is the most
divergent segment, sharing only 60%
amino acid identity (Payne et al., 1996;
Payne, 1997), and suggesting TM2 the
responsible for ion binding.
In situ hybridization studies and PCR
techniques demonstrated that KCC2
mRNA is located in the CNS (Payne,
1997, Rivera et al., 1999), although it is
also found in PNS as demonstrated by
immunohistochemistry (IHC) and PCR in
dorsal root ganglion (Lu et al., 1999).
During development, KCC2 mRNA
exhibits low levels of expression in rat
hippocampal, cortical and retinal
neurons, which increase with maturation
(Clayton et al., 1998; Lu et al., 1999;
Rivera et al., 1999; Williams et al., 1999;
Vu et al., 2000). In adulthood, the KCC2
protein is abundant in most neurons
throughout the nervous system (Kanaka
et al., 2001), preferentially located in
dendritic areas of the hippocampus
(Rivera et al., 1999; Williams et al., 1999;
Gulyas et al., 2001) and the neocortex
(Fukuda et al., 1998a; DeFazio et al.,
2000).
1.2.3.2 Neuronal function of KCC2
The nature of GABAergic transmission,
excitatory versus inhibitory, is
determined primarily by the
electrochemical gradient for Cl-, which
depends on the intra- and extracellular
concentrations of Cl-. This
electrochemical gradient is mediated by
K+-Cl- cotransport and sets the reversal
potential for GABAergic mediated
responses (E
GABA-A
; the membrane voltage
at which GABA
A
 currents change their
direction). The first indications about
KCC2 being the cotransporter
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responsible for the proper establishment
of Cl- currents in mature neurons, and
hence the proper GABAergic trans-
mission, were acknowledged by Payne
and collaborators (Payne et al., 1996;
Payne, 1997). The fact that KCC2 was
only expressed in neurons indicated that
this isoform displayed unique functional
characteristics. In addition, IHC studies
colocalized KCC2 with GABA
A
receptors, suggesting a putative role of
KCC2 in neuronal Cl- extrusion and post-
synaptic inhibition. This role, was finally
confirmed by Rivera and collaborators
(1999). Using antisense oligonucleotides
exposed to rat hippocampal slices, they
were able to demonstrate that the shift
from depolarizing to hyperpolarizing
actions of GABA that occurs during
neuronal maturation, is correlated with an
up-regulation of KCC2 mRNA expression
(Rivera et al., 1999).
The importance of KCC2 in the
regulation of CNS excitability has been
established by the characterization of
mice with targeted deletion of the KCC2
gene. Disruption of Kcc2 results in a
failure of hyperpolarizing inhibition that
leads to early postnatal death due to an
abnormal muscle tonus, defects in motor
control, and to an inability to breathe
(Hubner et al., 2001). Additionally,
hypomorphic KCC2 gene-targeted mice
show phenotypical variability according
to their expression levels of KCC2 (Woo
et al., 2002;Vilen et al., 2001).
Consequently, hypomorphic animals with
20-30% of the normal KCC2 levels are
viable and have no obvious behavioural
abnormalities (Woo et al., 2002), whereas
mice with only 5-10% of KCC2 display
spontaneous, generalized seizures and die
shortly after birth (Vilen et al., 2001).
Thus, reduction in KCC2 expression
results in an increased susceptibility to
the development of seizures. Therefore
the early function of KCC2 might be
critical during brain development and the
formation of brain circuitry.
In this context, a potential role for
KCC2 in diseases that involve seizure-
induced phenotype such as the human
epilepsy has been suggested. The human
KCC2 is located on chromosome 20q
(Song et al., 2002). Although this arm of
chromosome 20 contains two epilepsy
genes, there is no linkage with the
segment containing the KCC2 gene. This,
however, does not exclude the possibility
that KCC2 constitutes a modulating
factor for epilepsy. In this context, it is
important to note the work by Cohen and
collaborators (Cohen et al., 2002) in
finding the grounds of epileptic activity
in the human hippocampus. Performing
electrophysiological recordings in
hippocampal tissue surgically removed
from epileptic patients, they
demonstrated that a subpopulation of
pyramidal neurons from the sclerotic
CA1 hippocampal region are
depolarizing in response to the GABA
released by the interneurons. These
abnormal responses from the pyramidal
neurons supported by the activity of the
interneurons result in a pathological
synchronized excitation and initiates
epileptic activity. Whether these
depolarizing effects of GABA are linked
to a low expression of the KCC2 in
pyramidal neurons, or how this decrease
is related to seizure activity, is open up for
investigation.
1.2.3.3 KCC2 regulation
The molecular mechanisms behind the
regulation of KCC2 are currently under
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study. Nevertheless, several reports have
already provided insights for the
understanding of the regulatory
mechanisms controlling KCC2 during
development and mature situations.
Localization of a canonical tyrosine
phosphorylation site in the carboxy
terminal region of KCC2 suggests that
KCC2 regulation may occur by protein
phosphorylation. In that context,
biochemical experiments have shown that
cultured hippocampal neurons initially
contain an inactive form of the KCC2
protein, which becomes activated during
subsequent maturation. That process can
be accelerated by insulin-like growth
factor-1 (IGF-1) and can be reduced by
the application of membrane-permeable
protein tyrosine kinase inhibitors (Kelsch
et al., 2001). These results suggested that
the activation of KCC2 during
development might be dependent upon
growth factor-mediated tyrosine kinase
phosphorylation. However, Stein and
collaborators (2004) have recently
demonstrated that phosphorylated KCC2
was detectable early in the spinal cord
development when the functional GABA
switch had not yet occurred, indicating
that tyrosine phosphorylation seems to be
less important for the functional switch
than the transcriptional up-regulation of
KCC2.
Other molecules that might contribute
to the intracellular regulation of KCC2
have been described by using a yeast two-
hybrid screening (Inoue et al., 2004). The
experiments indicate that the C-terminal
region of KCC2 interacts with an ATP-
generating enzyme, the brain-type
creatine kinase (CKB). This interaction
was also detected in cultured cells and
brain extracts. The authors suggest that
CKB might provide ATP to modulate the
activity of KCC2, but the functional role
of this interaction is not yet evident.
In an attempt to investigate whether
synaptic activity can regulate the switch
of GABAergic transmission, Ganguly and
collaborators (Ganguly et al., 2001),
found that in mouse hippocampal
cultures KCC2 expression is under the
control of GABA
A
 receptor-mediated
transmission. The level of KCC2 mRNA
was reduced by chronic blockade of
GABA
A
 receptors and increased by
chronic depolarization with KCl. Their
results suggested that GABA itself acts as
a critical maturation factor for the switch
of the physiological and biochemical
properties of GABA signaling. However,
this statement is currently under debate.
Recently published reports have shown
that hyperpolarizing inhibition may
develop without trophic support of
GABA. Titz and collaborators (Titz et al.,
2003) found the existence of a switch in
GABAergic responses from depolarizing
to hyperpolarizing in cultured midbrain
neurons even when GABA
A
 receptors had
been blocked throughout development,
providing conflicting evidence that
GABA itself is not required for the
neuronal developmental switch. On the
other hand, using both dissociated as well
as organotypic hippocampal cultures (a
more physiological approach), Ludwig
and collaborators, showed that the
developmental up-regulation of KCC2
mRNA expression as well as the protein
levels, were not altered by chronically
GABAergic blockage (Ludwig et al., 2003).
The up-regulation of the KCC2
mRNA at early developmental stages has
also recently been shown by Aguado and
collaborators (Aguado et al., 2003). The
authors showed an increase in KCC2
expression paralleled with an increase in
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spontaneous network activity in the
hippocampus of mice overexpressing
BDNF that exhibit neither an increase in
the expression of GABA nor glutamate
ionotropic receptors, thus suggesting a
role of BDNF in the regulation of KCC2
expression. Whether the effect of BDNF
on KCC2 expression during development
involves a direct or indirect molecular
mechanism is not known.
Overall, the molecular mechanisms
behind the regulation of KCC2 still need
to be elucidated. An open question is
whether this essential protein is self-
regulatory or might be regulated in
concerted action with other proteins (i.e.
maybe with CCC members or even
unrelated proteins).
1.2.4 Chloride homeostasis and trauma
Traumatic insults to the brain (contusion,
epileptic seizures or hypoxia–ischemia)
cause excessive release of glutamate that
leads to elevated [Ca2+]
i
 and to excitotoxic
cellular damage and death (Lipton, 1999).
Additionally, GABA
A
 receptor-mediated
responses after trauma have been shown
to be depolarizing as a result of an
increase in [Cl-]
i
 (Katchman et al., 1994;
van den Pol et al., 1996; Fukuda et al.,
1998b; Nabekura et al., 2002) and,
consequently, the excitatory actions of
GABA after trauma contribute to
neuronal damage by increasing even more
cytosolic Ca2+ levels in injured cells.
In rat hippocampal pyramidal neurons
GABA
A 
receptor-mediated currents are
depolarizing at birth, but the resting
potential of GABA (E
GABA
) becomes
progressively more negative during early
postnatal maturation, indicating a
decrease in [Cl-]
i
 during development
(reviewed in Ben-Ari, 2002).
Nevertheless, in mature neurons, the
same embryonic GABA and glycine
receptor-mediated depolarizing responses
have been shown under some
pathophysiological conditions such as
trauma (van den Pol et al., 1996;
Nabekura et al., 2002; Toyoda et al.,
2003), and epilepsy (Köhling et al., 1998;
Cohen et al., 2002).
Interestingly, the elevation in neuronal
[Cl-]
i
 and depolarizing action of GABA
A
receptors that occur after trauma appear
to be mainly caused by alterations in
KCC2 expression. In this context, down-
regulation of KCC2 mRNA expression
has been observed after focal cerebral
ischemia-induced excitotoxicity (Galeffi
et al., 2004), and it seems to be a general
early response involved in various kinds
of neuronal trauma (Nabekura et al.,
2002; Coull et al., 2003; Malek et al.,
2003; Toyoda et al., 2003). In addition, a
dramatic loss of KCC2 protein has been
observed after sustained interictal-like
activity induced in hippocampal slices in
the absence of Mg2+ (ref. Thomas-
Crusells, et al. 2000).
The functional significance of the
depolarizing action of GABA after injury
has been suggested to be related to an
attempt from the neurons to recapitulate
ontogenic programs in which they have
greater developmental plasticity for
recovery (van den Pol et al., 1996;
Cramer and Chopp, 2000; Payne et al.,
2003). However, whether these programs
imply neuronal survival remains
unknown.
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2. AIMS OF THE STUDY
The present work has been conducted under the general aim of elucidating the
significance of the interplay between neurotrophins and chloride homeostasis under
normal and pathological conditions.
The specific aims of the study were:
• To analyze the effect of neurotrophins on the expression and function of KCC2
in intact adult rodent hippocampus and under pathophysiological conditions in
vivo and in vitro.
• To develop a simple and reliable method for detecting surface membrane protein
trafficking changes in hippocampal tissue, in order to study the regulation of
the KCC2 trafficking.
• To characterize the molecular mechanisms involved in the activity-dependent
regulation of KCC2 by using both in vivo and in vitro models of altered patterns
of neuronal activity, in order to elucidate the intracellular signaling pathways
involved.
• To study the effect and potential role of neurotrophins on KCC2 in neuronal
survival after in vivo injury.
Aims of the Study
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3. MATERIALS AND METHODS
The methods used are described in detail
in the “Materials and Methods” section of
the respective publications. All
experimental procedures using laboratory
animals were performed according to
ethical guidelines approved by local
authorities.
3.1 ANIMALS AND TISSUE PREPARATION
Experimental animals are described in I-
IV. Young and adult NMRI (II) and
C57BL/6 (I) mice, adult mice from a
BDNF- mutant strain (IV) (Korte et al.,
1995), NT-3- deficient mice (Airaksinen
et al., 1996), adult mice from TrkBPLC/PLC-
, TrkBSHC/SHC- and TrkBW/W (III)-mutant
strain (Minichiello et al., 2002), and
Sprague-Dawley (I, IV) and Wistar (III)
rats were housed under conditions of 12-
14h light and 10-12h darkness cycles,
receiving food and water ad libitum. On
the day of experimentation, animals were
anesthetized in a CO
2
 chamber and
sacrificed by cervical dislocation
followed by decapitation (I-III), or
anaesthetized with a combination of
chloral hydrate/sodium pentobarbital for
surgical procedures, and sacrificed by an
overdose of sodium pentobarbital before
transcardial perfusion (IV).
3.2 TISSUE PROCESSING
Acute and organotypic hippocampal
slices were processed and maintained as
described in I-III and elsewhere (Stoppini
et al., 1991; Lahtinen et al., 2001). For
experiments that required fixed tissue,
brains were either quickly removed and
immediately frozen on powdered dry ice
for later fixation (I-III), or brains from
animals previously transcardially
perfused with PBS followed by 4% PFA,
were post-fixed in PFA, cryoprotected in
20% sucrose in PBS, frozen in dry ice
cooled isopentane, and cryosectioned
(IV).
3.3 BIOTINYLATION OF CELL SURFACE
PROTEINS
Biotinylation procedure of acute
hippocampal slices, homogenate
preparation of surface biotynilated slices,
and measurements of protein turnover
rates experiments are detailed in II.
3.4 IN SITU HYBRIDIZATION AND
QUANTIFICATION OF MRNA EXPRESSION
The protocols for radioactive in situ
hybridization performed on brain cryostat
sections are described in I, III and IV.
Non-radioactive in situ hybridization of
free-floating sections from acute
hippocampal slices is described in II and
III and in Nieto et al., 1996. The cRNA
probes used are described in Table 2.
Quantification of hybridization signals
for KCC2, BDNF and TrkB mRNAs in
the hippocampus is described in I and III.
The method of quantification of KCC2,
GAP-43 and Tα1-tubulin mRNAs levels
in CSNs is detailed in IV and in McCabe
et al., 1989. The controls were performed
by competition with an excess of cold
probe and with sense mRNAs probes.
3.5 IMMUNOHISTOCHEMISTRY AND
WESTERN BLOTTING
The procedures for both IHC and Western
blotting detection are described in I, II
and III. The antibodies used in both
procedures are presented in Table 3. In
Materials and Methods
thesis.pmd 24.5.2004, 14:2725
26
the IHC experiments samples in which
the primary antibodies were omitted were
used as controls. Non-specific labeling
was not detected in any case. For Western
blots, and according to the experiment,
antibodies detecting proteins with known
turnover rates, neuronal specific
structural proteins and intracellular
proteins, were used as a controls.
3.6 RT-PCR
The protocol for total extraction of
mRNA from rat hippocampal slices and
the PCR amplification are described in II
and III and previously in Rivera et al.,
1999. Total RNA from the slices was
extracted with Trizol (Sigma) using a
modified version of the protocol by
Chomczynski and Sacchi, 1987. Total
RNA was reverse transcribed (RT) using
random hexamer primers and Superscript
II reverse Transcriptase (Life
Technologies Inc.).
3.7 ELECTROPHYSIOLOGICAL
RECORDINGS
The protocols for electrophysiological
recordings are described in I, II and III.
Evoked field potentials were measured
from rat CA1 pyramidal cells from acute
and/or organotypic hippocampal slices
using glass microelectrodes filled with
150 mM NaCl and 50mM of the spiking
blocker QX-314, and were recorded with
MED64 multichannel recording system
(I) or with an Axoclamp 2B amplifier in
bridge or discontinuous mode (II, III).
3.8 IN VIVO KINDLING AND AXOTOMY
PROCEDURES
Fast kindling protocol in which a direct
stimulation of the ipsilateral
hippocampus is applied, was used in our
in vivo kindling experiments. This
experimental model of epilepsy differs
from the hypothalamic kindling protocol
in which increased susceptibility appears
after a long period of daily stimulation.
The description of the kindling protocol
is detailed in I and in Kokaia et al., 1999.
Control animals were operated but did
not receive stimulation.
The axotomy procedure performed
in the study IV of this thesis is based on
a unilateral lesion at the level of the
internal capsule (IC) region where all
axons of the corticospinal neurons of the
sensory motor cortex converge. To
distinguish CSNs from other cortical
layer 5 neurons, they were retrogradely
labeled by fluorescent trace injections to
the corticospinal tracts at cervical spinal
cord levels C4/5 before axotomy. Fast
Blue (FB; 2% in 0.2% DMSO) and/or
rhodamine tracer mixture (RDX; 15%
rhodamine dextran 10,000, 10%
rhodamine dextran 3000, and 10%
rhodamine-β-isothiovyanate in 0.2%
DMSO) were used as tracers. The
unlesioned contralateral side of the brain
is the lesion control. The coordinates for
stereotaxic lesion and intracortical
neurotrophic factor delivery are described
in IV and elsewhere (Giehl and Tetzlaff,
1996; Bonatz et al., 2000). The
neurotrophic factors and intracortically
infused antibodies are listed in Table 4.
3.9 NEURONAL SURVIVAL ANALYSIS
The analysis of survival of rat and mouse
CSN is described in IV and in Bonatz et
al., 2000. The number of surviving CSN
was assessed by blinded cell counts of
every second section collected for cell
counts (i.e. every fourth section of the
mice and every 10th section of the rat
Materials and Methods
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brains). The criterion for a CSN was a
tracer-filled pyramidal-shaped profile of
>4 mm (rats) and >3 mm (mice) in
diameter. For the quantitative survival
data, only the data from the cell-death
areas were used (the cell death area spans
from the frontal level of the anterior
commissure 2.8 and 1.6 mm in posterior
direction in rats and mice, respectively.
See Bonantz et al., 2000) Within the cell
death area, percentage of survival is
defined as number of fast blue-labeled
CSN on the lesion side divided by the
number of fast blue-labeled CSN in
contralateral to the lesion side x 100%.
Materials and Methods
Probe Specie Lenth Nucleotides Reference Genbank  no. Used in
TrkB mouse 483 517-882 Klein et al., 1989; Hiltunen et al., 1996 X55573 I
Kcc2 mouse 1039 4605-5566 Payne et al., 1996 AA982489 I, III
Bdnf rat 366 517-882 Hiltunen et al., 1996 M61178 I, III
Kcc2 rat 35 2981-3016 Kanaka et al., 2001 U55816 IV
Gap-43 rat 51 220-270 Basi et al., 1987 - IV
Tα1-tubulin rat 50 1548-1594 Ginzburg et al., 1986 - IV
Table 2. List of probes used for in situ hybridization
Table 3. List of antibodies used for immunohistochemistry (IHC), Western
blotting (WB) and Biotinylation assay (BT).
Antibody/Antigen Host Source/Reference Dilution Method Used in
GluR1 gt Santa Cruz 1:1000 WB II
Transferin Receptor mo Zymed Laboratories 1:2000 WB II, III
MAP2 rb Chemicon 1:2000 WB II
KCC2 rb Payne et al.,1996 1:1000 WB I-III
 1:600 IHC II
rb B2C/Rivera et al., 1999 1:5000 WB I-III
  1:200 IHC III
αTubulin (DM1A) mo Sigma-Aldrich 1:5000-1:10000 WB I, III
pCREB rb Upstate Biotech 1:1000 WB III
HRP-IgG mo Sigma 1:4000 BT II-III
HRP-IgG rb Sigma 1:4000 BT II-III
goat-HRP do Amersham Pharmacia 1:3000 IHC II
goat-Cy3 do Jackson Lab  1:200 IHC II
FITC-IgG gt Jackson Lab   1:200 IHC III
TRITC-IgG gt Jackson Lab     1:200 IHC III
gt, goat; mo, mouse; rb, rabbit; do, donkey 
thesis.pmd 24.5.2004, 14:2727
28
Materials and Methods
Infusion contents Concentration Source/Reference Dilution
PBS 20mM Sigma
BDNF 500µg/ml in PBS Amgen
RAB* 1mg/ml in PBS Amgen/ Yan et al., 1997b
anti-TrKB serum Amgen/ Yan et al., 1997b; Kang et al., 1997 1:7
anti-TrKC serum Amgen/ Yan et al., 1997b; Giehl et al., 2001 1:7
preTrkC serum Amgen
Mab#21/27** 1mg/ml in PBS Amgen/Korsching and Thoenen, 1987 
mouse-IgG 1mg/ml in PBS Sigma
TrkB-Fc 60µg/ml in PBS Amgen
KCC2-AS" 9µg/ml Institute of Biotechnology, Univ. Helsinki
Random" 9µg/ml Institute of Biotechnology, Univ. Helsinki
All solutions contained penicillin/streptomycin in a final contentration of  50U/ml
* affinity purified BDNF-neutralizing rabbit polyclonal anti-BDNF antibody
**anti-NGF antibody "KCC2 anti-sense, and random oligonucleotides 
"KCC2 anti-sense and random oligonucleotides
Table 4. List of intracortically infused substances
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4. RESULTS AND DISCUSSION
4.1 PATHOLOGICAL ACTIVITY ALTERS
THE EXPRESSION OF KCC2 (I-III)
Altered patterns of activity as well as
different types of traumatic insults are
known to induce long-term effects on
neuronal Cl- regulation that result in
changes in the GABAergic transmission
(Payne et al., 2003). Since the neuron-
specific K+/Cl- cotransporter KCC2 is a
key regulator of chloride homeostasis
(Rivera et al., 1999; DeFazio et al., 2000;
Kakazu et al., 2000; Hubner et al., 2001),
it is imaginable that these changes would
affect both the expression and the
function of KCC2. To address this
possibility, we performed in vitro and in
vivo experiments in mice and rat
hippocampus.
4.1.1 Effect of pathological spontaneous
activity on KCC2 mRNA and protein
expression
In order to study the effects of neuronal
activity on the KCC2 mRNA and protein
expression in vivo, we examined the
effects of kindling-induced seizures in the
mouse hippocampus. Strikingly, after in
vivo hippocampal kindling–induced
seizures the KCC2 mRNA decreased in
all hippocampal regions (I, Fig. 4A). In
the dentate gyrus (DG) granule layer, a
large decrease in KCC2 mRNA
expression was already observed 2 h after
kindling (55 ± 2%), and the lowest level
was reached after 6 h (30 ± 3%). After 24
h, KCC2 mRNA levels had partially
recovered (77 ± 3%). The KCC2 mRNA
levels in the CA1 and CA3 regions were
significantly lower than in control
animals, and did not recover within 24 h.
At the protein level, a general decrease in
KCC2 immunostaining was found 6 h
after kindling (I, Fig. 4B). A regional
comparison of these data with in situ
hybridization results showed that the in
vivo kindling-induced changes in KCC2
mRNA were directly translated into
corresponding alterations in protein
expression. These results suggested that
the expression of KCC2 could be down-
regulated by pathophysiological activity.
We also examined the effects of
spontaneous activity on KCC2 expression
in vitro in acute hippocampal slices that
had been induced to interictal-like
activity by withdrawing Mg2+ from the
extracellular solution (Anderson et al.,
1986; Mody et al., 1987). By using
rodent hippocampal slices we also had the
possibility of detecting membrane
trafficking changes in KCC2 protein
expression (see explanations below) as
well as perform electrophysiological
recordings in order to detect possible
functional alterations due to the
trafficking changes in KCC2.
Additionally, previewing experimental
analysis of genetically mutated mice
strains in order to study KCC2 in regards
to its possible molecular mechanisms of
activity, using the 0-Mg2+in vitro model
that emulates epileptogenetic conditions
was thought to be the most adequate.
RT-PCR experiments and in situ
hybridization of KCC2 mRNA
expression in hippocampal slices under
Mg2+-free (0-Mg2+) conditions clearly
showed a down-regulation of the
expression of KCC2 mRNA that was
detectable already after 30min and
continued up to 3h exposure to 0-Mg2+
solution (III, Fig.1A). The expression was
recovered to control levels when slices
had been treated in normal medium
Results and Discussion
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Results and Discussion
conditions containing Mg2+, or by adding
a combination of glutamate activity
blockers (NBQX and AP5) into the
medium prior to exposure to 0-Mg2+
conditions (III, Fig. 1B). Western blot
analysis of slices treated under the same
conditions, also showed down-regulation
of the KCC2 protein and the levels were
rescued in slices that had been exposed to
a combination of pharmacological
activity blockers (III, Fig. 1C-D). Non-
radioactive in situ hybridizations of free-
floating sections that were treated with
the convulsant drug 4-AP, showed a
strong down-regulation of KCC2 (III,
Fig. 3A). Western blot analysis of the
same slices revealed a decreased level of
the KCC2 protein (III, Fig. 3B). In
addition, inmunofluorescent staining of
acute hippocampal slices exposed to the
0-Mg2+ solution revealed an area-specific
decrease of KCC2 showing a strong
reduction in staining intensity in CA1
dendritic region (III, Fig. 2). This is an
interesting finding also in the light of
recent evidence that suppression of
dendritic inhibition is strongly pro-
convulsant (Cossart et al., 2001).
Overall, these results indicate an
activity-dependent down-regulatory
effect on the expression of KCC2, and
supported our hypothesis that
pathophysiological activity would affect
the main key regulator of chloride
homeostasis.
4.1.2 Analysis of the degradation rate of
membrane KCC2 in hippocampal slices
Most of what is known about the
intracellular trafficking of a variety of
physiologically important membrane
bound and transmembrane proteins are
derived form studies using in vitro cell
surface biotinylation. However, these
experiments are either performed on cell
lines or dissociated primary neuron
cultures. In order to study trafficking of
KCC2 protein in the same experimental
paradigm (hippocampal slices) used in
our experiments (I and III), we developed
a surface membrane biotinylation
technique to study membrane protein
trafficking in the adult rodent
hippocampal slice preparation (II). This
should allow us to address the role of
trafficking on the regulation of KCC2
function in an organotypic, i.e.
physiologically relevant, context.
In order to examine the efficiency of
the biotinylation in a complex tissue slice
spanning several cell layers, we used a
peroxidase amplification assay to detect
the presence of bound biotin. After 1h of
incubation, complete penetration of the
biotinylation reagent into the acute
hippocampal slices was detected in fixed
transversal sections from hippocampal
slices (II, Fig. 2). Biotinylation of
intracellular proteins such as MAP2 was
not detected by immunohistochemistry,
ensuring that the labeling was exclusively
at the cell surface.
To assure the viability of the tissue,
electrophysiological recordings were
performed directly on the biotinylated
slices. Normal extracellular evoked field
responses in the CA1 region upon
stimulation of Schäffer collaterals were
obtained in labelled slices, up to 1h after
slice preparation. Furthermore, lowering
the Mg2+ concentration in the bath
solution increased the number of
population spikes evoked by a single
stimulation (II, Fig. 3) showing that the 0-
Mg2+-induced increase in the excitability
was maintained in the preparation. These
results indicate that the biotinylisation
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procedure affects cell surface proteins
throughout the entire slice, and that the
slice remains viable during the
preparation.
To further validate the method, we
studied the degradation kinetics of the
Transferrin receptor (TfR) and the
Glutamate receptor subunit A (GluR A).
The kinetics of both membrane proteins
has already been well established by other
approaches (Mammen et al., 1997;
Horikawa and Nawa, 1998; Lok and Loh,
1998). TfR was our control protein since
it is known to escape degradation by
recycling back to the cell membrane (for
review see Lok and Loh, 1998), whereas
GluR A is known to present a fast
degradation rate in hippocampal cell
cultures (Mammen et al., 1997; Horikawa
and Nawa, 1998). Homogenates of
biotynilated slices were precipitated with
streptavidin and analysed by Western
blots (II, Fig. 4). By using
immunoprecipitation of biotynilated
protein with streptavidin beads we
reduced possible problems of erroneous
detection of endogenous biotin. Our
results showed a high rate of degradation
of GluR A and no significant degradation
of TfR within the time window used,
corroborating previously studied
membrane trafficking changes of these
two receptors in dissociated cell cultures,
and thus validating our new methodology.
Taken together, we were able to
establish a new method that offers the
advantage of assessing protein trafficking
in an organotypic situation. Obviously,
this setting is significantly closer to the
physiological situation than dissociated
cultures. A constraint of the method is
that it is more difficult to follow organelle
distribution in neurons that are
maintained in their organotypic context,
than in neurons kept under dissociated
culture conditions. In addition, acute
slices placed on a one-side perfused
planar channel recording system cannot
be maintained viable for more than 5 or
6 h (Oka et al., 1999), therefore
restricting the time window in which the
method can be applied. Thus, our system
represents a manoeuvre to quantitatively
study acute membrane protein changes in
a physiological condition.
As demonstrated above (see section
4.1.1), the activity-specific down-
regulation of KCC2 took place at a
transcriptional level resulting also in
decreased levels of KCC2 protein.
However, we could not rule out that
changes of KCC2 mRNA stability and/or
alterations of KCC2 protein trafficking
contributed to this phenomenon. Having
established a method to assess protein
trafficking in acute organotypic slices, we
now addressed the question whether
activity also affected the trafficking of
KCC2 between cell surface and
intracellular compartments. Our
biotinylation assays revealed that KCC2
protein displays a strikingly fast turnover
rate under Mg2+-free conditions (III, Fig.
4). The rate of decay was significantly
reduced when a combination of activity
blockers was applied to 0-Mg2+ exposure
conditions, indicating that the KCC2
membrane protein was regulated in an
activity-dependent manner. Accordingly,
the activity-dependent increase in the
turnover of the plasmalemmal KCC2
transporters enhances their susceptibility
to transcriptional down-regulation that
was detected at the transcriptional level in
the previous experiments (see section
4.1.1).
Results and Discussion
thesis.pmd 24.5.2004, 14:2731
32
Results and Discussion
Altogether, these fast modifications
suggest that activity-dependent KCC2
regulation plays a role in synaptic
plasticity.
4.1.3 Effect of spontaneous activity on
the KCC2 function
The generation and maintenance of the
chloride gradient required for
hyperpolarizing ionotropic responses in
CNS neurons in general, and the CA1
region of the hippocampus in particular,
is attributed to the neuron-specific K+–Cl-
cotransporter, KCC2 (Thompson and
Gahwiler, 1989; Kaila, 1994; Rivera et
al., 1999; DeFazio et al., 2000; Kakazu et
al., 2000; Hubner et al., 2001).
To examine the functional
consequences of the decreased expression
of KCC2 (I, III) on neuronal Cl-
extrusion, we measured the inhibitory
postsynaptic potential (IPSP
A
) reversal
potential (E 
IPSP-A
) in CA1 pyramidal
neurons from acute hippocampal slices
exposed to 0-Mg2+ conditions (III, Fig. 5).
The neuronal E 
IPSP-A 
was measured in
hippocampal slices and dissociated
neurons subjected to a tonic chloride load
with a 0.5 M Cl—containing sharp
microelectrode in the presence of the
activity blockers (NBQX plus AP-5). The
results obtained showed that 0-Mg2+-
induced activity led to a decrease in the
efficacy of Cl- extrusion, indicating that
the predicted fall in plasmalemmal KCC2
was paralleled by an activity-dependent
impairment in the efficacy of Cl-
extrusion by pyramidal neurons. These
results also shed light on previous
findings from in vivo and in vitro models
of epilepsy as well as for human epileptic
tissue which have demonstrated a positive
shift in the driving force of GABA
A
-
mediated inhibition, which is sometimes
sufficient to change the postsynaptic
response from hyperpolarizing to
depolarizing (Tasker et al., 1992; Kapur
et al., 1995; Köhling et al., 1998; Cohen
et al., 2002).
4.2 KCC2: A LINK BETWEEN
NEUROTROPHINS AND CHLORIDE
HOMEOSTASIS (I, III)
Among their well-known effects on
neuronal survival and differentiation
(Huang and Reichardt, 2001),
neurotrophins have been reported to be
involved in synapse formation and
functional maturation (Marty et al., 1997;
Huang and Reichardt, 2001). In addition,
in the adult brain, experimental
paradigms involving strong stimulation
such as in vivo kindling are known to lead
to a very strong up-regulation and release
of BDNF and to an activation of its
receptor TrkB. This is thought to
predispose cortical areas to seizures due
to, at least in part, on the effects of fast
GABAergic inhibition. (Binder et al.,
2001; Huang and Reichardt, 2001).
Keeping this in mind, the activity
dependent effects on the expression of
KCC2 (I, III) could involve neurotrophin
and/or neurotrophin receptor modulation.
In order to address this hypothesis, we
analyzed the effect of BDNF and  NT-4/
5 and NGF on KCC2 expression in acute
and long term cultured organotypic
hippocampal slices, and in in vivo
kindling paradigms. For these studies, we
used material from wild type rats and
from TrkB mutant mice.
thesis.pmd 24.5.2004, 14:2732
33
4.2.1 Fast down-regulation of KCC2 is
associated with BDNF and its receptor
TrkB
In organotypic hippocampal cultures,
application of the TrkB receptor ligands
BDNF and NT-4/5 resulted in a clear
down-regulation of KCC2 mRNA, as
shown by RT-PCR (I, Fig. 1A).
Application of NGF, which acts via TrkA,
or heat-inactivated BDNF and NT-4/5,
had no effect on the KCC2 expression
levels (unpublished data). Western blot
analysis indicated that the effects of
BDNF were dose-dependent, with
maximum decrease of KCC2 expression
at a dose of 100ng/ml BDNF (I, Fig. 1B).
Both RT-PCR and Western blot analysis
showed that the effect after BDNF and
NT-4/5 treatment was abolished when
TrkB was inhibited by the tyrosine kinase
inhibitor K252a, and by depletion of
these ligands with soluble TrkB-Fc fusion
receptor bodies (TrkB-Fc). When TrkB-
Fc was added without any combination of
NTs, the levels of KCC2 increased. That
suggested that endogenous neurotrophin
pathways mediate the effect, i.e. that the
modulation is physiologically relevant (I,
Fig. 1C). Nevertheless, the fact that the
effect of TrkB-Fc was smaller than the
effect after application of K252a may
suggest that other endogenous trophic
factors in addition to BDNF may have a
small contribution to this process, or that
TrkB maintains ligand independent
baseline activity. Interestingly, inhibition
of network activity by tetrodotoxin (TTX)
or by glutamate blockers (CQNX and
AP5), did not inhibit the down-regulation
of KCC2 by BDNF (I, Fig. 1D),
indicating that the TrkB-mediated effects
on KCC2 were not caused by a general
increase in neuronal excitability and
network activity (Scharfman et al., 1997;
Kafitz et al., 1999; Scharfman et al.,
1999). The same type of experiments on
acute hippocampal slices exposed to 0-
Mg2+ showed similar results (III, Fig. 6 A
and B). In this regard, application of
K252a to the slices did not affect the
expression of neither KCC2 mRNA nor
the protein, whereas the down-regulation
of KCC2 was decreased by the presence
of TkB-Fc. These results further
supported our conclusion that BDNF/
TrkB mediates the effect of activity
dependent modulation of KCC2.
To examine possible functional
consequences of BDNF-induced changes
in KCC2 expression, we exposed acute
hippocampal slices to 100–200 ng/ml
BDNF for different periods of time. Free-
floating in situ hybridization of acute
slices showed that KCC2 mRNA levels
were down-regulated in all hippocampal
regions after 3 hours of BDNF treatment
(I, Fig. 2A). Western blots show that the
reduction of KCC2 protein was already
detectable after 2 h of incubation, and
became even more pronounced after 4 h
(I, Fig. 2B). This brief time delay may
reflect a number of steps, including the
diffusion of BDNF into the slice and the
activation of TrkB-mediated signaling
cascades, and was in agreement with the
consequent changes in KCC2 expression
observed in all experiments done.
Electrophysiological recordings on
acute hippocampal slices exposed to
endogenous BDNF for up to 4h (I, Fig. 3)
showed an impaired capacity of Cl-
extrusion in CA1 hippocampal neurons.
These findings reveal that the BDNF-
induced reduction of KCC2 expression
has a functional consequence on neuronal
Cl- extrusion.
Results and Discussion
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As described above (see section
4.1.1), the KCC2 mRNA decreased in all
hippocampal regions, and most
significantly in the dentate gyrus (DG),
after in vivo hippocampal kindling–
induced seizures (I, Fig. 4A). BDNF and
TrkB expression after kindling is most
pronounced in the DG (Bengzon et al.,
1993; Binder et al., 1999). In several
epilepsy models, the time course of up-
regulation of BDNF protein levels has
been shown to follow its mRNA levels
with a 4 hours delay starting in the DG,
followed by the hilus and CA3 stratum
lucidum at 12–24 h after stimulus (Binder
et al., 2001). In agreement with previous
data (Bengzon et al., 1993), the
expression levels of TrkB and BDNF
mRNAs showed a time-dependent
increase upon kindling-induced seizures.
In our experiments, TrkB mRNA levels
increased bilaterally in all hippocampal
regions with a prominent peak after 2 h in
the granule cells of the DG (160 ± 5% of
control), returning to control levels after
6 h. The increase of TrkB mRNA levels in
CA1 and CA3 was not as steep as in the
DG, but remained high 6 h after kindling
(138 ± 2% in CA1, 139 ± 3% in CA3)
and returned to control values after 24 h.
BDNF mRNA showed a strong increase
in all hippocampal regions with a 3–5-
fold increase over control levels 2 h after
kindling. The BDNF mRNA levels
gradually returned back to control values
after 24 h, except for the DG that still
showed elevated levels (198 ± 5% of
control).
Altogether our data reveals a novel
mechanism whereby BDNF/TrkB
signaling suppresses chloride-dependent
fast GABAergic inhibition. By affecting
the expression of KCC2, BDNF/trkB
activation alters the efficiency of neuronal
chloride extrusion and therefore alters the
global inhibitory action of GABA
A
-
mediated responses. This mechanism
most likely contributes to the well-known
role of TrkB-activated signaling cascades
in the induction and establishment of
epileptic activity.
4.2.2 Dissection of TrkB activated
intracellular pathways involved in
mechanisms of activity-induced
reduction of KCC2 expression (I, III)
BDNF binding to TrkB induces receptor
tyrosine phosphorylation followed by the
activation/inhibition of downstream
proteins, including the activation of the
transcription factor cAMP response
element-binding protein (CREB)
(Finkbeiner et al., 1997; Bibel and Barde,
2000; Minichiello et al., 2002).
Using an antibody that specifically
recognizes phosphorylated CREB (anti
phospho-CREB), we were able to detect
an increase in phospho-CREB
immunoreactivity in acute hippocampal
slices exposed to 0-Mg2+ (III, Fig. 7A).
The signal was visible in the CA1 region
and the DG after 1h exposure, becoming
more robust after 3h. After 3h exposure,
also the CA3 region showed activated
CREB. Using Western blot analysis, we
compared CREB and KCC2 expressions
on 0-Mg2+ superfused (3h) hippocampal
slices in the presence or absence of TrkB-
Fc. These experiments showed that
scavenging of endogenous BDNF blocks
CREB phosphorylation (III, Fig. 7A).
Overall these results indicated that
interictal-like activity-induced CREB
phosphorylation is mediated by TrkB, and
its BDNF-induced spatio-temporal
pattern of activation, previously reported
by Finkbeiner and collaborators
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(Finkbeiner et al., 1997), correlates with
the KCC2 down-regulation (III, Fig. 2).
The recent generation of two strains of
TrkB gene mutated animals (Minichiello
et al., 2002) have been the key for
demonstrating that PLCγ and Shc/FRS-2
are the two major intracellular cascades
involved in plasticity-related effects of
BDNF in the hippocampus. While a
single amino acid-targeted mutation of
the TrkB gene on the Shc/FRS docking
site shows that PLCγ-CREB signaling is
necessary for LTP, a mutation in the PLCγ
docking site indicates that Shc/FRS-2 is
not required (Minichiello et al., 2002;
Ernfors and Bramham, 2003).
In order to identify the signaling
mechanisms required for BDNF/TrkB-
mediated KCC2 down-regulation, we
used hippocampal slices from wild type
(TrkBW/W) and transgenic animals
(TrkBPLC/PLC and TrkBSHC/SHC). Different
sets of acute hippocampal slices were
exposed to exogenous BDNF or to 0-
Mg2+solution for 3-4h. As expected,
Western blot analysis showed that, in both
situations, KCC2 levels were down-
regulated in the wild type animals. In the
TrkBSHC/SHC mutants, the expression of
KCC2 was not affected, indicating that
the Shc/FRS-2 coupled pathway is
important for KCC2 down-regulation. To
our surprise, in both BDNF- and 0-Mg2+-
exposed slices from TrkBPLC/PLC mice,
KCC2 expression was significantly up-
regulated (III, Fig. 8). Taken together,
these results indicate that the BDNF-
mediated activation of the Shc pathway is
crucial for both the down-regulation and
the up-regulation of KCC2. Down-
regulation of KCC2 appears to take place
if the Shc pathway is activated in
conjunction with the PLCγ cascade. In
turn, the Shc pathway acting in the
absence of the PLCγ cascades triggers
KCC2 mRNA up-regulation.
During maturation, an increase in the
expression of KCC2 is required for a
functional postsynaptic inhibition in the
central nervous system (Rivera et al.,
1999). Additional studies will be required
to elucidate whether this developmental
up-regulation is controlled by the same
mechanisms.
4.3 BDNF/ KCC2-DEPENDENT SURVIVAL
OF LESIONED ADULT NEURONS (IV)
Trophic support embraces multiple
parameters such as the regulation of
neuronal plasticity, axonal and dendritic
growth, and survival. Recently, it has
been suggested that damaged neurons
switch trophic support in favor to
recapitulate ontogenic programs of
plasticity (for see reviews of Cramer and
Chopp, 2000; Payne et al., 2003). As for
the neurotrophin dependent regulation of
KCC2 expression, there are apparently
two different modes of regulation in adult
versus immature neurons: while BDNF
appears to up-regulate KCC2 mRNA
expression in embryonic hippocampus
(Aguado et al., 2003), our own data show
that BDNF mediated TrkB activation in
adult hippocampal neurons results in a
down-regulation of the expression of
KCC2. As depicted, this down-regulation
impairs Cl- extrusion and, hence, alters
GABAergic transmission.
In the light of these observations, we
tested the hypothesis that lesion of adult
neurons re-activates a developmental
mode of neurotrophin mediated KCC2
regulation. We used the corticospinal
system as an experimental model because
corticospinal neurons (CSNs) express
TrkB receptor and are rescued from
Results and Discussion
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axotomy-induced death by BDNF
(reviewed in Giehl, 2001). In addition,
KCC2 is strongly expressed in the adult
neocortex, with highest levels in cortical
layer V, where the cell bodies of CSNs are
located (Giehl et al., 2001; Nabekura et
al., 2002). KCC2 expression was
assessed using semiquantitative in situ
hybridization techniques (Giehl et al.,
1998). The effect of neurotrophic factors
on the expression of KCC2 was studied in
intact and lesioned animals that received
intracortical infusions of different
neurotrophins, antibodies and carrier
solutions using a mini-pump perfusion
system. The procedure is depicted in
detail in IV (see IV, Fig. 1).
4.3.1 Axotomy-induced switch of
BDNF-mediated KCC2 regulation in
corticospinal neurons.
To examine the effects of BDNF on
KCC2 expression in adult CSNs, we
infused BDNF for 7 days in the frontal
cortex of intact and lesioned animals in
which CSNs were identified by
retrograde tracing. Coronal sections of
the brain were processed for in situ
hybridization of KCC2 mRNA and the
levels of expression quantified. BDNF
decreased KCC2-expression 0.4-fold in
intact CSNs, and increased KCC2-
expression 1.8-fold in lesioned CSNs (IV,
Fig. 2). Comparing the expression levels
of the lesion with the respective control
sides revealed that KCC2 expression is
down-regulated in CSNs after axotomy
(IV, Fig. 3). Analysis of the time course of
the BDNF effects on KCC2 expression
shows that the BDNF induced up-
regulation was already fully established at
day 1 after the injury, the time point when
all lesioned CSNs are still alive (Giehl
and Tetzlaff, 1996). These data showed
that axotomy switches BDNF-mediated
KCC2 regulation from down-regulatory
in unlesioned to up-regulatory in lesioned
adult CSNs. The switch to an embryonic
mode of regulation coincides with a shift
of the KCC2 expression to low levels
after axotomy and suggests a reactivation
of a developmental program in adult
CSNs after injury.
4.3.2 Corticospinal neurons reactivate
developmental programs of trophic
support to survive after axotomy
In order to address the functional context
of the lesion-induced switch, we next
examined whether the trophic
requirements of CSNs change after
axotomy and become reminiscent of the
trophic regulation in the embryonic
cortex.
All embryonic cortical neurons (E17/
18) depend on endogenous BDNF for
survival. Since adult CSNs require
endogenous BDNF after axotomy (Giehl
et al., 1998), we examined whether they
also require this factor while still intact.
Quantification of CSNs in aged mice of
a BDNF knockout strain (Korte et al.,
1995) revealed that the heterozygous
mutants have virtually identical CSNs
numbers as their wild-type counterparts
(IV, Fig. 4A). As survival of axotomized
CSNs is severely decreased in
heterozygous BDNF mutants (Giehl et
al., 2001), neurotrophins appear to
mediate their survival effects on CSNs in
a dose-dependent manner. Thus, our data
showed that BDNF is not required for the
survival of intact adult CSNs. This
finding is in line with the previous notion
that acute neutralization of BDNF does
not affect the survival of intact CSNs
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(Giehl et al., 1998). Thus, adult intact
CSNs do not require BDNF for survival
but switch to BDNF-dependency after
axonal injury.
Since not only BDNF but also NT-4/
5 acts via TrkB (Barbacid, 1995), and
both factors are present in the adult cortex
(Timmusk et al., 1993; Kang et al., 1997)
it is conceivable that endogenous NT-4/5
compensates for the reduced BDNF
levels in the BDNF knockouts, and
sustains a TrkB activity that is sufficient
to support survival of intact but not
lesioned (Giehl et al., 2001) CSNs. To
address this issue, we intracortically
infused a polyclonal TrkB antibody for 7
days to intact and lesioned CSNs. TrkB
blockade dramatically reduced the
survival of lesioned CSNs while the
survival of intact CSNs was not affected
(VI, Fig. 5). These data indicated that
CSNs switch from BDNF/TrkB-
independency in the intact state to BDNF/
TrkB-dependency after axotomy. Since
also embryonic cortical neurons are
supported by endogenous BDNF for
survival (Ghosh et al., 1994), this switch
represents the reactivation of a
developmental mechanism for the
promotion of neuronal survival after a
pathological damage.
The observation that lesioned neurons
require the same survival factors as
developing neurons is not sufficient to
state that these cells reassume an
embryonic mode of survival regulation
after lesion. To this end, it is necessary
that other aspects of survival-regulation
such as the cell death promotion function
similar as during development. For
embryonic cortical neurons, NT-3, acts as
a differentiation factor causing cortical
precursors to adopt a neuronal phenotype
(Ghosh and Greenberg, 1995) and to
become dependent on BDNF (Ghosh et
al., 1994). To address the possibility that,
after lesion, NT-3 may cause BDNF-
dependence and thus lead injured adult
CSNs back into a situation similar to their
embryonic stage, we simultaneously
eliminated the survival signal (BDNF)
and the respective death signal (NT-3 or
proNGF) by intracortically infusing the
respective combinations of ligand
neutralizing antibodies.
Axotomized CSNs survived BDNF
withdrawal when NT-3 was
simultaneously neutralized (Giehl et al.,
2001) (VI, Fig. 5C) indicating either (1)
that the death inducing signal is
dominant, or (2) that NT-3 is required for
the BDNF-dependence. However, the
death-promoting signal per se was not
dominant since a significant proportion
of BDNF dependent CSNs died when
both BDNF and proNGF were
simultaneously neutralized (VI, Fig.
5A,C). The results indicated that NT-3
promotes death by causing the BDNF-
dependency of CSNs after the lesion,
while proNGF acts as the death-executing
signal for those CSNs that are
insufficiently supplied with BDNF. Thus,
also NT-3 reassumes a role for adult
lesioned CSNs, which is similar to its role
during development, i.e. it cause the
dependency of CSNs on BDNF for
survival.
The question remained whether the
lesion specifically activates this function
of NT-3, or whether NT-3 physiologically
maintains the dependence of intact
mature CSNs on a survival-promoting
factor. To address this question, we
examined the role of endogenous NT-3
for intact CSNs in 1.5 year-old mice of a
NT-3 knockout strain (Airaksinen et al.,
1996). CSNs numbers were virtually
Results and Discussion
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identical in both heterozygous and wild
type animals (VI, Fig. 4B) suggesting that
NT-3 does not affect the survival of intact
CSNs, but becomes important for the
survival regulation after the lesion. Thus,
adult CSNs reactivate a developmental
program for survival regulation after
axonal injury.
Lesion-induced reactivation of
ontogenetic programs has been addressed
in the context of regeneration or increased
plasticity (Tetzlaff et al., 1994; Dechant
and Barde, 2002; Cramer and Chopp,
2000). In order to investigate whether the
lesion-induced switch in KCC2
regulation was as well part of a general
activation of developmental programs
including regeneration, we analyzed the
expression of two regeneration associated
proteins, Tα1-tubulin and the growth
associated protein 43 (GAP-43), which
are both elevated during axonal growth
and increased plasticity (Tetzlaff et al.,
1994; Plunet et al., 2002), and the
expression of p75NTR, which is induced
during neuronal death induction (Giehl et
al., 2001; Dechant and Barde, 2002).
Tα1-tubulin and GAP-43 mRNA levels
were decreased in lesioned CSNs (VI,
Fig. 6A) showing that regeneration- or
plasticity-associated gene expression was
not induced. In contrast, lesioned CSNs
strongly up-regulated p75 mRNA
expression (VI, Fig. 6A). Thus,
axotomized CSNs reactivate
developmental programs primarily
associated with survival-regulation, but
not regeneration or increased plasticity,
hence associating KCC2-regulation with
the regulation of neuronal survival.
Nevertheless, this does not exclude the
possibility of proximal sprouting and
rewiring of axotomized neurons.
4.3.3 KCC2 is associated with
recovery from neuronal injury.
A significant portion of lesioned CSNs
recovers from the injury (Giehl et al.,
1997). To corroborate the association of
KCC2 with survival-regulation after
injury, we examined whether KCC2
levels are recovered in CSNs that survive
the initial injury period, and whether this
coincides with a loss of the injury
specific survival-regulation. Indeed,
KCC2 mRNA levels were recovered by
day 42 after the lesion and even slightly
exceed the KCC2-levels in CSNs of the
intact control side (VI, Fig. 6C). This
recovery was coincident with a loss of the
BDNF-dependency of lesioned CSNs
since the application of BDNF-
neutralizing antibody at such a late stage
after the lesion did not result in additional
CSNs-death (VI, Fig. 6B). Thus, lesioned
CSNs appear to re-establish mature
KCC2 regulation and trophic support
after an initial post injury period. By
increasing KCC2 levels after axotomy,
BDNF might have a second function in
addition to survival promotion: It might
also promote maturation that eventually
leads to switching off the BDNF-
dependency.
4.3.4 Does KCC2 have a role in CSN
survival mechanisms?
Our data suggest that the lesion induced
switch of KCC2 regulation is involved in
the regulation of neuronal survival. To
test the hypothesis that KCC2 is directly
involved in the establishment of the
trophic dependency of injured CSNs, we
depleted KCC2 levels in intact CSNs by
infusing KCC2 antisense
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oligonucleotides (Phosphothionate
dideoxy oligonucleotides, PODNS) into
one cortical hemisphere. Our preliminary
results using this procedure show that
KCC2-PODN significantly reduced the
survival of intact CSNs when it was
applied in combination with BDNF-
blocking antibodies (see Fig. 8, here
presented as unpublished data). In
contrast, application of KCC2 antisense
alone did not reduce the survival of
unlesioned CSNs indicating that
endogenous levels of BDNF are able to
sustain CSNs. Additionally, application of
random antisense did not affect the
survival of unlesioned adult CSNs
therefore assuring that their survival was
not altered by the infusions applied nor by
the methodology used. In addition, CSNs
were not affected when combined
infusions of random antisense and TrkB
fusion bodies were supplied,
corroborating the correlation observed
between KCC2 expression and survival
of CSNs. To our surprise, combined
application of KCC2 antisense and TrkB-
Fc did not result in death of CSNs. This
might be due to a problem in the
concentration of TkB-Fc applied. The
survival of adult CSNs was neither
affected by the administration of BDNF
nor by BDNF-blocking antibodies
reassuring that unlesioned adult CSNs do
not require BDNF for survival.
Altogether, these finding shows that
down modulation of KCC2 is required for
the installation of BDNF dependency.
Additional experiments regarding the
regulation of KCC2 will be needed to
elucidate whether the implication of
Fig. 8. KCC2 depletion affects survival of adult CSNs. (A) Photomicrographs of representa-
tive unlesioned (n=5) Fast Blue-labeled CSNs in cortical layer V after intracortically infused
solutions of BDNF (n=1), BDNF-neutralizing antibodies (RAB, n=4), KCC2-antisense oli-
gonucleotides (KAS, n=4), random oligonucleotides (Rand, n=4) or a combination of oligo-
nucleotides and BDNF-neutralizing antibodies (Rand+RAB, n=2; KAS+RAB, n=3). (B) Plot
of the survival analysis of the same treatments described in (A) in unlesioned CSNs as well as
of infusions of TrkB-neutralizing antibodies (TBFc, n=2) and combination of oligonucle-
otides and TrkB-neutralizing antibodies (KAS+ TBFc, n=3). (means ± SEM; ANOVA:
Rand+TBFc vs. TBFc P<0.01; Rand+TBFc vs. KAS+RAB ul P<0.1; KAS ul vs. TBFc P<0.01;
KAS ul vs. KAS+RAB ul P<0.1).
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Fig. 9. Under pathological conditions adult neurons simultaneously activate developmental
patterns of [Cl-]
i
 and neurotrophin regulation  (dotted arrow), which are probably interacting
to regulate neuronal survival and to promote plasticity and recovery after damage.
Results and Discussion
KCC2 in the survival of CSNs is a result
of KCC2 regulation on itself and/or is due
to concerted actions with other proteins
(i.e. CCC members or even proteins that
do not belong to the CCC-family).
To summarize, the results indicate that
in vivo axotomy induces corticospinal
neurons to switch their neurotrophin- and
KCC2-mediated survival regulation to a
developmental mode. This suggests that,
after injury, adult neurons simultaneously
activate developmental patterns of
GABA- and NT regulation, which
probably interact in order to regulate
neuronal survival and to promote
recovery in a critical post-injury phase.
The molecular mechanisms involved
clearly indicate that BDNF/TrkB is a key
survival pathway, that proNGF/p75NTR
represent the death inducing signal, and
NT-3 would be “the” or “one” essential
signal for the initiation of the lesion-
specific functional antagonism of BDNF
and proNGF on survival regulation. This
embryonic, lesion-induced program is
restricted to a few weeks after injury with
both neurotrophin and KCC2 regulation
reassuming their pre-injury state (VI, Fig.7).
The findings might be important for
the development of therapeutic strategies
that aim at diseases involving neuronal
death. This work further emphasizes that
approaches to foster neuronal survival
have to take into consideration whether
the target neuron is in a “lesion mode” or
an “intact mode”.
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5. CONCLUDING REMARKS
1. The expression and function of KCC2 is affected by altered patterns of activity
and axotomy and it is regulated by BDNF/TrkB activation. The BDNF-mediated
TrkB activation induces a decrease in the expression of KCC2 in mature neurons
that leads to an impairment of Cl- extrusion that suggests a reestablishment of
developmental patterns of chloride homeostasis.
2. The time-window of the KCC2 expression at transcriptional and translational
level, together with the downstream molecular mechanisms involved in the
BDNF-mediated regulation of KCC2, suggest a role of KCC2 in manifestations
of neuronal plasticity.
3. The BDNF-mediated KCC2 regulation switches from down regulatory in intact
to up regulatory in lesioned adult corticospinal neurons. This switch coincides
with a shift of the KCC2 expression to low levels after axotomy. Both suggest
that developmental programs are reactivated in adult corticospinal neurons after
injury. In addition, the findings show that neurotrophins and KCC2 interact in
vivo, and that this interaction is subjected to a lesion induced change.
4. Axotomy induces also a switch in the trophic dependency of adult neurons to
a developmental mode of neuronal survival regulation, with endogenous NT-3
acting as a conditioning signal for BDNF-dependent survival. The ontogenetic
reactivation is temporarily restricted which allows the neurons to acquire
plasticity for functional adaptation in a critical post-injury period. Blockage of
KCC2 expression in adult CSNs results in neuronal death, suggesting that
KCC2 is a key regulator for the establishment of ontogenetic programs of
survival regulation in lesioned CSNs. Overall, these findings suggest that lesion
induced embryonic programs also apply to the regulation of neuronal survival.
Our findings may be important for the development of treatment strategies for
neurological disorders involving neuronal death.
A summary of the concluding remarks of this thesis is depicted in Fig.9
Concluding Remarks
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